TSS:Rfhg 195841.1

Basic information about the TSS

---

TSS ID: rfhg_195841.1 TSS ID(Version3): hg_161717.1 hg_161716.1 hg_161718.1 Species: human Chr: chr17		Start: 50744685 End: 50744785 Strand: +
Source datasets	FANTOM5|DRA000914|PRJNA401781|PRJNA615891|PRJNA4843412 |DRA013844|PRJDB5282
Protocol	CAGE|TIF-seq2|SLIC_CAGE|NETCAGE|C1CAGE
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000504065.5:-24 GeneID: 51747 HGNC/MGI_ID: HGNC:24309 UniProt_ID: H0YA81 Nearer transcript ids and distances:

Gene_name: LUC7 like 3 pre-mRNA splicing factor Gene_symbol: LUC7L3 Gene_synonyms: CRA CREAP-1 CROP FLJ11063 LUC7A OA48-18 hLuc7A Gene_source: HGNC:24309

TATA-Box annotation

---

Distance to TSS:	22783
Nearest PromoterID:	NM_001358683
Entrez ID:	55018
Nearest Unigene:	Hs.389460
Nearest Refseq:	NM_017928
Nearest Ensembl:	ENSG00000167117
Gene Name:	LUC7 like 3 pre-mRNA splicing factor
Gene Alias:	C17orf73|LINC00483
Gene Type:	protein-coding
CpG%:	0.010000
GC%:	0.445545
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LUC7L3 p2@LUC7L3 p3@LUC7L3 p4@LUC7L3 p5@LUC7L3 p6@LUC7L3 p7@LUC7L3 p8@LUC7L3 p9@LUC7L3 p10@LUC7L3
Sample		p1@LUC7L3	p2@LUC7L3	p3@LUC7L3	p4@LUC7L3	p5@LUC7L3	p6@LUC7L3	p7@LUC7L3	p8@LUC7L3	p9@LUC7L3	p10@LUC7L3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	141.43	3.51	0.58	4.68	1.95	1.75	1.75	0.97	0.78	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	137.58	3.64	0.61	4.65	2.02	2.02	2.23	1.62	0.81	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	172.26	5.21	0.58	4.44	3.09	2.70	3.09	0.39	1.35	2.70
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	111.86	3.33	0.62	1.46	1.46	1.04	1.87	0.21	0.42	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	140.83	1.35	0.67	2.47	0.45	2.25	0.67	0.22	0.22	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	139.54	3.29	0.58	3.10	2.91	1.36	2.52	1.55	1.55	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	134.43	1.09	0.87	3.05	1.53	1.31	1.53	0.65	0.44	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	116.99	0.73	0.48	1.94	2.66	1.70	1.70	0.24	0.24	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	101.52	2.14	0.43	1.07	1.71	0.64	0.85	0.21	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	75.35	1.16	0.58	0.00	0.58	0.00	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	76.40	1.21	0.40	1.21	0.81	0.81	0.40	0.40	0.00	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	78.87	0.81	0.81	0.00	1.63	0.81	0.00	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	81.40	3.06	1.77	1.45	1.61	1.45	0.32	0.97	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	78.63	3.46	0.75	0.60	1.05	0.90	0.75	1.35	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	76.84	4.17	0.22	1.54	1.54	0.88	1.32	0.88	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	62.12	2.01	1.01	1.01	1.01	1.26	0.75	0.75	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	55.04	0.44	0.66	0.44	0.00	0.22	0.22	1.31	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	66.65	1.27	1.27	2.11	1.27	2.95	0.42	2.11	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	68.78	2.13	1.07	1.07	1.07	0.53	0.00	0.00	0.00	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	66.65	1.50	1.65	0.75	0.90	1.35	0.60	0.60	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	74.04	2.54	0.94	1.20	1.60	1.07	1.47	1.60	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	62.83	3.80	1.21	1.55	1.21	0.35	0.35	0.52	0.17	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	62.82	2.84	1.29	0.90	0.65	0.65	0.78	1.03	0.13	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	69.40	2.67	1.70	0.73	0.73	0.49	0.97	0.49	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	58.31	2.32	0.52	1.55	1.55	0.26	0.00	0.52	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	64.88	2.53	2.22	0.63	0.32	1.27	0.63	0.95	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	61.54	3.30	2.75	0.55	1.10	0.55	1.65	1.65	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	76.62	4.72	0.71	1.65	0.94	0.94	0.24	0.94	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	58.63	0.97	0.97	1.45	1.62	0.65	0.65	0.32	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	69.31	2.17	0.36	0.54	0.36	0.72	0.72	1.27	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	54.22	2.30	0.63	0.63	0.84	0.42	0.42	1.05	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	57.25	1.17	1.76	0.39	0.20	0.98	0.39	0.78	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	57.19	2.53	1.69	1.06	1.27	0.84	0.84	0.84	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	82.47	2.64	0.82	0.49	1.15	0.33	0.49	0.49	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	64.14	2.43	0.56	0.75	0.75	0.37	0.37	1.12	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	65.54	4.02	0.77	1.34	1.92	0.00	0.77	0.77	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	56.20	1.43	0.61	0.61	1.23	0.61	0.41	0.61	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	50.98	1.21	0.81	0.81	0.60	0.40	0.40	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	62.93	1.62	1.62	1.35	2.16	0.27	0.81	0.54	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	57.37	2.40	1.20	0.48	0.72	0.24	0.72	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	52.93	1.88	0.47	0.24	0.24	0.24	0.24	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	68.95	1.90	0.73	0.59	0.59	0.73	0.59	0.29	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	55.47	2.53	1.05	0.84	0.21	0.42	0.21	1.48	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	57.34	3.32	0.35	0.00	0.17	0.70	0.52	1.40	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	55.61	3.61	1.61	0.40	1.00	0.80	0.40	1.00	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	57.00	3.26	2.09	2.09	0.47	1.40	0.93	1.63	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	49.42	1.44	0.72	0.24	0.24	0.00	0.24	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	44.71	2.38	0.60	0.30	1.19	0.00	0.00	0.89	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	45.72	2.63	0.96	0.72	0.00	0.00	0.24	1.68	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	45.70	1.01	1.01	0.00	0.61	0.40	0.00	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	52.06	3.28	0.41	0.41	1.43	0.61	0.20	0.20	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	48.48	3.34	0.89	0.00	1.56	0.67	0.67	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	4365.56	279.84	0.00	55.97	55.97	55.97	69.96	97.95	41.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.71	2.84	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	44.07	0.66	0.66	0.99	0.33	0.00	0.33	0.00	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	381.72	10.07	3.36	7.55	10.91	4.19	5.87	10.91	5.87	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	84.96	5.51	0.46	1.84	0.46	0.00	0.92	0.92	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	37.60	3.57	0.97	0.32	1.62	0.00	0.00	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	38.22	2.57	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	70.41	3.14	0.94	0.94	0.94	1.26	1.26	1.26	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	4.23	0.00	0.00	0.00	0.00	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	37.57	0.56	0.56	0.56	1.12	0.00	0.00	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	116.24	13.53	3.98	3.98	6.37	6.37	0.80	10.35	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	62.86	3.06	1.02	0.68	1.70	1.02	1.02	0.68	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.89	1.62	0.65	0.32	0.00	0.32	0.32	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.01	1.42	0.71	0.00	0.71	0.35	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	3636.88	96.98	0.00	64.66	96.98	32.33	32.33	32.33	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	2519.30	63.18	0.00	39.49	31.59	15.79	15.79	39.49	23.69	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	38.03	2.44	1.95	0.98	1.95	0.49	0.49	1.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	30.74	0.50	0.50	0.50	0.00	0.00	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	33.31	1.41	0.47	0.94	0.94	0.00	0.00	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.67	3.31	0.33	0.33	0.00	0.33	0.33	1.32	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	40.21	2.17	0.31	0.31	0.93	0.00	0.62	1.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	32.41	2.45	0.92	0.61	0.61	0.31	0.31	0.61	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	39.60	0.16	0.63	0.16	0.16	0.00	0.00	0.00	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	44.60	3.21	0.80	0.00	0.32	0.32	0.00	0.32	0.16	0.32
Adipocyte - omental, donor1	11473-119C6	51.15	1.53	0.51	0.13	0.25	0.13	0.13	0.13	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	32.89	0.00	3.74	1.49	0.00	0.00	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	39.19	0.33	2.34	0.00	0.00	0.00	0.00	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	29.35	0.00	3.19	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.00	0.45	0.00	0.00	0.45	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	17.20	0.52	0.00	0.35	0.17	0.17	0.35	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	70.60	0.39	0.59	0.20	0.20	0.20	0.39	0.00	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	56.11	1.54	0.00	0.26	0.00	0.26	0.00	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	34.57	0.84	0.56	0.28	0.00	0.00	0.28	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	65.25	1.18	0.00	0.00	1.18	0.00	0.00	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	112.28	0.56	0.40	0.32	0.24	0.08	0.16	0.00	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	51.96	0.00	0.97	0.32	0.00	0.32	0.65	0.00	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	43.19	1.07	0.53	0.53	0.00	0.53	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	52.31	0.56	1.67	0.56	0.00	0.00	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	37.43	0.42	0.83	0.00	0.00	0.83	0.00	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	34.41	0.25	0.50	0.00	0.25	0.25	0.25	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	37.31	0.00	0.33	0.00	0.33	0.00	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	36.84	0.00	0.61	0.00	0.00	0.30	0.30	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	6.85	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.77	0.18	0.36	0.18	0.00	0.00	0.18	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	28.49	0.23	0.11	0.57	0.11	0.11	0.11	0.00	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	16.90	0.24	0.49	0.00	0.00	0.00	0.24	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	37.29	0.45	1.80	0.45	0.00	0.45	0.00	0.00	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	38.20	0.43	1.30	0.00	0.43	0.43	0.43	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	2.14	2.14	0.00	2.14	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.27	0.30	0.90	0.90	0.60	0.00	0.60	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	37.94	0.00	1.26	0.00	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.80	1.32	0.00	0.66	0.66	0.00	0.66	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	35.09	0.65	0.32	0.00	0.00	0.00	0.65	0.65	0.00	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	39.32	1.94	1.46	0.49	1.46	0.49	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.94	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	38.79	1.88	0.75	1.13	1.13	0.38	0.38	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	0.73	0.73	0.73	0.00	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.40	0.00	0.16	0.16	0.00	0.00	0.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	1.36	1.36	1.36	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	24.28	0.00	0.75	0.00	0.00	0.15	0.15	0.00	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	35.36	1.07	1.07	0.54	0.54	0.54	0.00	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.91	0.76	1.13	0.00	0.00	0.19	0.19	0.76	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.92	1.60	0.00	1.07	0.53	0.27	0.53	0.00	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	26.34	1.95	0.98	0.00	0.98	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	28.36	1.00	1.33	0.83	0.17	0.33	0.17	0.33	0.17	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	35.34	0.86	0.69	0.86	0.51	0.86	0.51	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	40.29	3.40	1.46	0.97	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	32.25	1.52	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	0.00	2.42	0.00	2.42	0.00	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.64	0.57	0.00	0.57	0.57	0.00	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	31.42	0.86	1.50	1.28	0.21	0.00	0.43	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.52	2.32	0.26	0.00	1.03	0.26	0.26	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.93	0.47	0.94	0.94	0.00	0.47	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.41	0.00	0.64	0.32	1.61	0.64	0.32	0.32	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	23.54	0.00	0.71	0.00	0.00	0.00	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	26.32	1.75	0.58	0.00	0.00	1.17	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.60	0.90	0.00	1.51	0.30	0.30	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	40.68	2.54	1.02	0.00	0.00	0.00	1.02	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	34.89	1.53	1.78	1.02	0.25	0.25	1.02	0.25	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.48	1.73	0.43	0.00	0.86	0.00	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.98	0.21	0.42	0.64	0.00	0.64	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.72	0.87	0.58	0.29	0.00	0.00	0.00	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	25.51	2.83	0.94	0.94	0.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.62	0.85	0.17	0.51	0.00	0.17	0.00	0.17	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	2.11	4.23	0.00	0.00	0.00	0.00	4.23	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.09	1.93	0.64	0.43	0.21	0.00	0.43	0.21	0.00	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	29.48	0.60	1.20	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	27.70	1.46	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.44	0.23	0.92	0.23	0.23	0.46	0.23	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	0.00	0.00	0.00	0.00	0.00	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.75	0.51	0.00	0.00	0.25	0.25	0.25	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	32.62	1.24	1.45	0.41	0.21	0.00	0.41	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	26.62	1.53	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.98	0.96	0.48	0.48	0.00	0.48	0.00	0.96	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	31.04	0.67	0.44	0.67	0.00	0.44	0.67	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	1.53	0.00	0.00	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.14	1.11	0.55	0.00	0.00	0.00	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	31.78	1.32	1.32	0.00	0.79	0.26	0.26	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.17	0.73	0.36	0.36	0.00	0.73	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	19.53	0.00	0.49	0.00	0.12	0.00	0.12	0.25	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	9.41	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.18	0.00	0.00	0.21	0.00	0.00	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	113.99	3.14	2.44	1.74	1.74	1.39	2.44	0.70	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	95.93	4.21	1.46	2.26	0.97	0.97	1.62	0.97	0.81	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	94.27	3.28	1.19	0.89	1.04	0.89	0.89	0.45	0.45	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	200.47	12.62	1.72	1.72	2.06	1.83	1.03	1.26	1.03	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	193.06	10.65	1.50	3.51	1.88	2.51	1.00	1.38	0.38	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	207.45	12.29	1.14	1.48	2.96	1.93	1.14	1.02	0.57	0.46
Basophils, donor1	12241-129G9	33.21	0.26	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	113.65	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.36	0.00
Basophils, donor3	12243-129H2	27.93	0.44	0.15	0.15	0.00	0.00	0.15	0.00	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.95	0.00	0.00	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	5.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	8.29	0.00	0.00	0.00	0.23	0.00	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	36.71	3.42	0.72	1.62	0.18	1.26	1.62	0.90	0.36	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	222.91	6.90	1.13	1.65	1.65	0.41	0.62	0.31	0.62	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	278.32	14.21	3.49	2.33	5.12	4.43	2.56	0.47	0.93	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	138.46	0.00	1.92	0.00	0.00	0.00	0.00	0.00	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	413.68	0.00	0.00	0.00	0.00	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	61.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	60.13	2.41	0.93	0.37	1.11	0.74	0.19	0.74	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	54.88	1.76	0.88	0.88	0.22	0.88	0.66	0.88	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	74.44	0.57	1.42	0.57	0.00	0.28	0.57	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	95.53	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	99.94	1.31	0.99	0.00	0.00	0.00	0.33	0.00	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	55.65	3.32	0.87	0.14	0.58	0.14	0.00	0.00	0.14	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	45.86	2.72	0.60	0.60	0.30	0.30	0.30	1.51	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	71.30	1.90	0.95	0.00	0.47	0.24	0.00	0.24	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	46.20	1.34	0.00	0.00	0.17	0.33	0.00	0.50	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.03	2.48	0.55	0.55	0.00	0.00	0.28	0.55	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.99	4.71	1.24	0.25	0.25	0.25	0.25	0.99	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	34.85	1.76	0.20	0.39	0.00	0.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	35.79	1.60	0.71	0.18	0.18	0.18	0.53	0.18	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	76.39	0.22	0.22	0.00	0.22	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	41.21	1.17	0.47	0.47	0.00	0.23	0.47	0.23	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	73.40	0.00	1.58	0.00	0.00	0.53	0.53	1.06	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	98.73	1.11	2.22	0.00	1.11	0.00	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	48.79	2.68	0.59	0.45	0.30	0.15	0.00	0.00	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	51.28	2.59	0.20	0.20	0.00	0.20	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	93.07	1.04	0.21	0.21	0.21	0.00	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	36.15	1.83	0.23	0.23	0.23	0.23	0.00	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	50.22	2.04	0.90	0.00	0.00	0.45	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	48.01	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	39.00	1.61	0.54	0.00	0.00	0.00	0.00	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	39.08	1.22	0.17	0.17	0.00	0.17	0.52	0.52	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	52.18	2.95	1.26	0.84	0.42	0.42	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	41.89	1.65	0.37	0.55	0.92	0.55	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	37.34	1.76	0.00	0.00	0.35	0.00	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	58.35	2.19	0.44	0.00	0.88	0.00	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	41.15	3.49	1.05	0.35	0.52	0.52	0.00	0.35	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	48.32	2.97	0.37	0.37	1.12	0.37	0.37	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	83.63	1.08	0.43	0.43	0.22	0.00	0.22	0.22	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	40.54	1.64	1.23	0.41	0.41	0.41	0.00	1.64	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	54.94	0.46	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	63.57	0.70	0.46	0.23	0.00	0.00	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	64.74	0.65	0.44	0.22	0.00	0.00	0.00	0.00	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	52.90	0.46	1.62	0.69	0.23	0.23	0.69	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	49.17	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	102.93	0.16	0.47	0.62	0.31	0.00	0.62	0.00	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	88.37	0.52	0.70	0.35	0.52	0.00	0.52	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	177.93	1.56	0.22	0.22	0.22	0.67	0.00	0.45	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	62.52	0.51	1.02	0.00	0.00	0.00	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	73.33	0.88	0.66	0.66	0.88	0.00	0.44	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	78.95	0.42	1.05	0.21	0.00	0.00	0.21	0.21	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	154.46	0.00	2.03	0.00	0.00	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	243.39	1.36	2.03	0.68	0.68	0.68	1.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	207.12	2.07	1.04	0.00	1.04	0.00	0.00	0.00	1.04	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	143.39	0.00	1.60	0.53	0.53	0.00	0.53	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	300.20	0.54	2.68	0.54	0.54	1.07	0.00	0.00	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	234.45	0.70	3.51	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	221.19	0.00	6.27	0.00	0.00	0.00	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	250.47	0.00	3.95	0.00	0.00	0.00	0.00	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	150.41	3.29	6.58	0.82	3.29	2.47	0.00	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	129.13	1.45	0.73	0.00	0.00	0.00	1.45	1.45	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	108.54	1.51	2.52	0.00	1.01	0.50	0.50	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	275.57	3.64	0.00	2.42	1.21	0.81	1.21	1.21	0.00	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	183.37	1.20	0.40	0.80	0.40	0.00	0.40	0.00	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	101.41	1.00	2.01	0.00	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	142.70	0.56	1.69	0.56	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	183.74	0.75	1.50	0.00	0.00	0.75	0.00	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	222.33	0.23	2.03	0.45	0.23	0.00	0.23	0.00	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	192.81	3.21	2.86	0.36	0.71	0.00	0.71	0.36	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	113.90	4.29	1.84	0.00	1.84	0.61	1.22	2.45	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	87.23	4.27	0.61	0.61	1.22	0.61	0.30	0.00	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	200.87	1.28	1.53	0.26	1.28	0.00	1.28	0.26	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	183.27	0.45	2.70	0.45	0.67	0.67	0.67	0.45	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	196.91	0.29	3.16	0.57	0.29	0.86	0.57	0.86	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	193.43	1.90	0.47	0.95	0.47	0.00	1.42	0.95	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	269.69	1.40	0.00	0.70	0.70	0.00	0.00	0.00	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	260.40	3.30	13.18	3.30	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	139.17	1.01	0.72	0.43	0.14	0.29	0.14	0.14	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	90.83	6.44	3.22	3.39	1.02	0.68	1.02	1.02	0.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	98.50	5.00	1.93	1.77	0.97	1.13	0.81	0.97	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	127.77	0.45	2.69	1.34	0.45	0.00	0.45	1.34	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	157.92	0.70	2.80	0.70	0.00	1.05	0.35	1.40	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	284.23	3.52	1.32	1.76	1.76	0.88	0.88	0.44	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	198.59	5.06	2.95	0.42	0.42	0.42	0.42	0.84	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	97.03	8.10	3.32	2.08	1.45	1.66	1.25	1.25	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	96.56	3.68	1.34	1.00	0.33	0.33	0.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	257.52	2.99	2.45	2.18	0.82	0.54	0.54	1.09	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	438.94	4.29	3.75	1.07	0.00	0.00	1.07	0.54	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	294.09	5.38	5.38	5.38	1.79	1.79	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	186.73	2.41	2.23	1.67	1.48	0.19	0.19	0.74	0.56	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	106.36	2.60	0.43	1.52	0.00	0.22	1.30	0.65	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	152.15	1.05	0.84	0.42	0.63	1.05	0.21	0.21	0.00	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	145.11	1.01	0.51	1.52	0.00	0.51	1.01	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	160.74	0.43	0.87	0.87	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	305.07	5.23	2.61	3.05	0.44	0.00	0.87	2.18	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	263.27	1.48	1.98	0.99	0.99	0.00	0.49	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	259.42	0.92	3.69	0.92	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	235.89	2.79	0.00	0.00	0.00	1.40	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	349.48	0.83	3.88	0.00	0.28	0.00	0.28	0.00	0.55	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	491.03	0.74	4.91	0.98	0.74	0.00	0.00	0.00	0.25	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	275.66	0.00	0.00	0.00	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	340.57	0.72	3.58	1.43	0.00	0.00	1.07	1.43	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	301.93	0.00	4.15	0.00	0.00	0.00	1.38	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	109.35	1.96	1.31	0.33	0.00	0.00	0.00	0.33	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	117.89	3.00	2.63	1.13	1.13	0.75	0.00	1.50	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	134.32	3.53	1.26	0.25	0.25	0.50	0.76	1.77	0.50	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	54.60	3.67	0.23	0.46	0.46	0.46	1.15	0.46	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	53.68	3.35	0.00	1.44	1.20	1.20	0.24	0.96	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.22	2.46	0.00	1.37	0.82	1.37	1.09	0.55	0.27	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	69.65	1.50	0.00	0.90	0.00	1.20	0.90	0.90	0.00	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	47.52	1.44	0.96	0.72	0.72	0.48	0.96	0.72	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	42.98	1.14	0.23	0.23	0.68	0.00	0.00	1.14	0.00	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	43.89	1.74	0.22	1.09	0.22	0.65	0.43	0.00	0.00	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	45.80	0.79	0.00	1.84	0.00	1.05	0.26	0.53	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	48.31	1.41	0.23	0.70	0.47	0.70	1.41	0.47	0.70	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	45.89	0.91	0.60	0.30	1.21	0.00	0.60	0.60	0.30	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	51.71	0.87	0.00	1.45	0.29	0.87	0.58	1.45	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	46.09	0.80	0.00	0.27	0.27	0.80	1.07	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.02	1.31	0.00	0.00	0.00	0.00	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	39.62	0.46	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.80	0.00	0.75	0.00	0.00	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	45.74	0.72	0.36	0.72	0.00	0.00	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	55.82	0.58	0.58	1.15	0.29	0.29	0.58	0.58	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	36.53	0.00	1.18	0.24	0.24	0.00	0.24	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	59.26	1.58	0.32	0.63	1.27	0.63	0.95	0.63	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	56.28	1.85	0.62	1.23	0.31	0.92	1.23	0.31	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	49.05	1.28	0.64	0.64	0.96	0.64	0.00	0.32	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	41.69	0.38	0.38	1.53	0.38	0.00	0.00	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	46.11	0.79	0.39	0.00	0.39	1.18	0.00	0.00	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	48.41	0.00	0.00	0.00	0.00	0.00	0.76	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	114.82	6.42	2.41	1.61	1.61	0.00	1.61	2.41	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	111.91	2.80	1.40	2.80	4.20	1.40	0.00	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	126.22	4.01	2.00	2.00	0.00	2.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	32.90	7.31	0.00	5.48	1.83	3.66	0.00	0.00	0.00	5.48
Cardiac Myocyte, donor2	11605-120I3	25.69	0.00	0.49	0.00	0.49	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	18.63	0.11	0.00	0.11	0.00	0.11	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	46.45	3.12	1.73	0.35	0.00	0.00	0.00	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	14.57	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	36.86	2.39	0.57	1.37	1.02	0.91	0.80	0.80	0.11	0.80
Chondrocyte - re diff, donor2	11339-117F7	65.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	31.14	0.81	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	109.59	1.26	1.26	0.46	0.46	0.46	0.34	0.34	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	60.92	2.99	1.07	1.07	1.07	0.86	1.50	0.43	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	70.98	3.89	0.62	1.50	1.24	0.88	0.97	0.18	0.27	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	43.65	1.19	0.18	0.64	0.18	0.46	0.09	0.00	0.00	0.00
Corneal Epithelial Cells, donor1	11526-119I5	3.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.92	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	40.78	0.50	0.66	0.00	0.00	0.17	0.00	0.00	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	31.54	0.95	0.32	0.00	0.32	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.00	0.65	0.00	0.65	0.76	0.00	0.65	0.11	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	152.37	1.02	0.68	0.34	0.34	0.68	0.68	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	169.75	1.31	1.31	0.65	0.00	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	245.84	0.48	3.87	0.00	0.00	0.00	0.00	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	15.84	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.04	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	16.29	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	38.35	0.71	0.00	0.47	0.47	0.24	0.00	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	12.97	0.00	0.00	0.18	0.00	0.00	0.00	0.18	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	55.41	0.44	0.22	0.22	0.00	0.22	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	62.07	0.61	0.91	0.30	0.30	0.30	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	84.01	0.56	0.28	0.28	0.00	0.56	0.28	0.28	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	13.37	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.34	0.43	0.14	0.43	0.43	0.28	0.14	0.00	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	53.62	0.40	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	21.49	1.05	0.00	0.00	0.00	0.00	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	136.80	1.12	1.49	0.50	0.25	0.62	0.25	0.12	0.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	88.43	1.30	0.87	0.43	0.87	0.00	0.43	0.00	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	94.89	1.22	0.12	0.24	0.24	0.12	0.49	0.24	0.24	0.49
Endothelial Cells - Vein, donor1	11267-116G7	14.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	20.57	0.16	0.00	0.63	0.16	0.16	0.31	0.00	0.00	0.16
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	66.01	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	39.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	34.89	4.11	0.41	0.00	0.00	0.82	0.41	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.23	0.33	0.00	0.11	0.11	0.11	0.00	0.00	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.78	0.43	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	56.76	0.36	0.24	0.73	0.36	0.24	0.36	0.00	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	169.36	1.64	2.05	1.23	0.55	0.55	0.68	0.41	0.41	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.02	1.90	0.63	0.00	0.32	0.32	0.21	0.32	0.00	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	110.40	0.53	3.69	0.26	1.05	0.26	0.53	0.79	0.00	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.52	2.99	1.66	1.00	0.33	0.33	0.66	1.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	19.51	0.45	0.45	0.45	0.00	0.45	0.45	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	13.64	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.98	0.47	0.47	0.00	0.32	0.16	0.32	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	81.54	0.00	0.30	0.30	0.30	0.00	0.00	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	64.09	0.89	1.40	0.25	0.00	0.00	0.25	0.00	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	45.48	0.45	0.76	0.00	0.00	0.00	0.15	0.00	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.43	0.13	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	27.18	0.43	0.43	0.43	0.00	0.86	0.00	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	0.00	0.00	0.00	0.00	0.00	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	13.38	0.69	0.00	0.00	0.00	0.23	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	61.06	0.68	0.00	0.68	0.68	0.17	0.85	0.51	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	40.38	0.70	0.47	0.23	0.23	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	38.56	3.02	0.24	1.93	0.73	1.81	2.06	0.24	0.00	0.73
Fibroblast - Dermal, donor4	11450-119A1	70.54	0.90	1.58	0.34	0.11	0.00	0.11	0.23	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	72.92	0.70	1.74	0.00	0.35	0.00	0.00	0.17	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	69.52	0.65	1.95	0.00	0.32	0.00	0.65	0.16	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	76.00	0.83	0.62	0.00	0.21	0.21	0.21	0.42	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	62.62	1.57	0.26	0.26	1.05	0.52	0.00	0.00	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	76.17	3.82	0.92	1.05	1.45	0.79	1.58	0.13	0.53	0.53
Fibroblast - Gingival, donor3	11394-118C8	85.37	0.97	0.19	0.58	0.29	0.10	0.19	0.29	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	55.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.77	1.76	0.35	0.88	1.23	0.35	0.70	0.35	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	70.62	2.49	0.47	1.40	0.62	0.47	1.40	0.31	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	52.87	2.03	0.54	0.27	0.81	0.68	0.54	0.27	0.00	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	22.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	54.70	1.32	0.73	0.15	0.44	0.15	0.44	0.15	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	70.22	1.64	0.27	0.68	0.27	0.55	1.09	0.55	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	61.65	1.76	0.22	0.33	1.10	0.22	0.22	0.66	0.33	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	76.89	1.03	0.88	0.44	0.73	0.29	0.59	0.73	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	2.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	74.61	1.49	0.00	0.00	0.00	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	30.39	0.84	0.00	0.42	0.21	0.00	0.00	0.00	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	11.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.43	0.00	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	82.24	1.55	0.39	0.58	0.78	0.58	1.36	0.78	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	111.64	2.12	0.91	0.30	0.76	0.46	0.00	0.15	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	104.65	0.31	0.00	0.31	0.31	0.00	0.00	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	48.08	1.14	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	37.26	0.27	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	37.11	0.81	0.23	0.12	0.00	0.46	0.46	0.00	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	33.38	0.66	0.11	0.11	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	10.97	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	151.02	3.57	1.79	0.60	2.38	0.60	0.79	1.98	0.40	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	67.85	2.13	0.71	0.53	0.53	0.36	0.53	0.71	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	69.18	1.18	0.20	0.20	0.59	0.39	0.59	0.20	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	105.00	1.20	2.41	0.90	0.90	0.30	0.60	0.00	0.00	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	107.52	0.65	1.08	0.32	0.32	0.00	0.43	0.11	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	164.25	1.52	1.77	2.02	1.01	1.01	0.51	0.51	0.76	1.27
Fibroblast - skin normal, donor1	11553-120C5	46.60	1.15	0.33	0.49	0.00	0.00	0.33	0.16	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	179.45	6.22	2.61	0.60	1.00	0.60	0.00	0.40	0.00	0.80
Fibroblast - skin normal, donor2	11561-120D4	77.66	0.30	0.70	0.00	0.30	0.00	0.00	0.10	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	138.73	2.42	2.12	2.72	1.21	0.00	1.21	0.00	0.00	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	75.89	0.58	0.83	0.17	0.17	0.41	0.25	0.17	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	131.80	0.68	1.71	0.34	0.51	0.00	0.00	0.51	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	149.44	1.97	2.63	0.33	1.97	0.00	0.33	0.33	0.00	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	80.53	0.43	0.85	0.00	0.00	0.00	0.11	0.11	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	34.58	0.67	0.00	0.51	0.00	0.17	0.17	0.17	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.62	0.16	0.31	0.16	0.00	0.00	0.16	0.16	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1196.63	22.16	0.00	22.16	22.16	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	71.47	3.49	1.74	0.00	0.87	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.47	0.35	0.17	0.17	0.00	0.00	0.00	0.00	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	45.28	1.04	0.00	0.00	0.52	0.00	0.00	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.75	0.26	0.51	0.77	0.00	0.00	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	50.53	0.77	0.00	0.77	0.00	0.00	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	58.06	4.47	1.28	0.64	0.64	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	137.78	9.13	0.57	7.13	1.43	1.43	2.57	1.71	1.43	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	196.89	18.48	4.69	6.62	6.34	4.14	5.79	1.93	1.93	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	127.41	7.53	2.51	1.83	3.42	2.74	1.83	0.46	0.46	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	104.81	9.31	1.39	1.98	2.18	1.59	2.58	0.79	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	185.83	21.41	2.64	5.29	4.76	2.64	5.55	3.70	1.59	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	141.55	7.83	0.98	1.30	2.61	1.30	0.98	0.98	0.65	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	119.40	11.50	3.54	5.75	3.54	3.98	3.10	2.21	0.44	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	115.46	4.24	0.71	0.57	0.71	0.14	0.71	1.27	0.57	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	98.51	3.20	1.48	1.97	1.11	0.49	0.99	1.35	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	76.02	3.76	1.07	1.07	0.81	1.34	0.54	0.54	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	78.18	1.98	0.62	0.50	0.37	0.37	0.25	0.12	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	72.95	2.08	0.97	1.52	0.83	0.69	1.66	0.55	0.69	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	71.16	3.66	0.61	1.02	1.42	0.81	0.61	0.81	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	67.31	1.83	0.46	1.14	0.46	0.68	0.68	0.68	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	86.82	2.74	0.75	1.00	0.37	1.00	1.25	0.37	0.00	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	65.35	2.40	0.22	0.66	0.22	0.44	0.66	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	80.96	2.95	1.77	1.18	1.48	1.18	0.30	0.00	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	103.16	2.70	0.95	1.11	0.79	0.64	2.23	2.54	0.79	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	52.28	0.67	0.67	0.89	0.22	0.00	0.45	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	91.74	4.23	1.81	2.42	1.81	1.21	1.61	0.81	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	112.13	3.39	0.51	2.54	0.68	0.68	1.02	0.51	0.34	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	97.98	1.68	0.44	0.27	0.18	0.27	0.09	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	150.47	1.77	0.42	0.10	0.00	0.00	0.10	0.00	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	146.36	0.68	0.17	0.17	0.17	0.00	0.17	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	100.36	3.10	0.89	2.21	1.22	0.66	1.00	1.00	0.33	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	104.00	1.33	0.50	1.00	0.17	0.25	0.00	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	102.50	0.61	0.41	0.20	0.00	0.41	0.20	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	90.16	3.51	2.27	1.24	1.24	0.21	0.41	0.21	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	96.96	2.08	1.96	1.50	1.27	0.35	0.58	1.84	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	87.05	3.17	1.17	1.33	1.17	0.50	0.83	1.00	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	55.77	1.98	2.87	0.44	1.10	0.66	0.44	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	98.64	4.18	0.49	1.23	0.74	0.61	0.86	0.61	0.25	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	89.48	3.24	1.78	2.27	1.46	0.49	0.81	0.81	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	73.44	1.92	1.60	1.28	2.25	0.32	0.00	0.96	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	68.32	1.90	0.95	1.99	0.38	0.47	0.85	0.38	0.19	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	49.98	1.11	1.11	1.27	0.95	1.11	1.27	0.47	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	60.51	1.22	0.30	1.52	0.91	0.30	0.30	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	71.30	1.88	1.05	0.94	0.73	1.15	1.36	0.94	0.21	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	59.72	3.95	0.66	0.44	1.54	1.32	1.10	0.00	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	62.84	2.52	0.84	1.40	0.84	2.52	1.40	0.00	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	55.55	2.22	0.09	0.00	0.28	0.19	0.19	0.46	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.80	2.14	0.27	1.60	0.27	0.80	1.07	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	51.72	1.84	0.46	1.22	0.31	0.15	0.31	0.46	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	55.05	1.30	0.65	0.65	0.78	0.65	0.65	0.26	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.90	0.54	0.54	0.00	0.00	0.27	0.27	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	64.34	2.77	1.29	1.47	1.11	0.92	0.92	0.55	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	53.51	3.07	0.44	1.32	0.88	0.44	0.44	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	146.78	2.98	0.99	0.00	0.00	0.00	0.99	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.18	0.79	0.66	0.40	0.66	0.79	0.26	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.00	0.81	1.41	0.61	0.40	0.40	0.61	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	181.72	0.76	0.25	0.00	0.00	0.00	0.25	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	186.52	2.39	1.99	0.40	0.40	0.60	0.80	0.80	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	130.35	7.55	1.08	3.24	1.08	1.23	1.54	1.23	0.31	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	169.39	6.55	1.23	3.07	1.02	1.64	0.82	1.84	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	63.84	0.00	0.94	0.00	0.00	0.00	1.25	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	67.81	0.57	0.85	0.28	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	127.75	6.46	3.23	1.84	1.84	1.38	0.92	0.92	1.38	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	101.47	2.47	0.00	2.47	2.47	0.00	2.47	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	120.68	5.42	1.16	1.55	1.93	0.39	0.77	0.39	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	128.36	6.42	0.00	1.60	1.60	0.00	1.60	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	5.22	0.00	5.22	0.00	5.22	12.17	5.22	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	101.55	4.56	2.60	2.60	0.65	0.65	0.98	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	142.90	7.00	2.06	2.88	0.82	0.41	1.65	1.24	1.65	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	129.96	13.33	0.00	13.33	13.33	6.66	19.99	6.66	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	128.08	4.47	1.96	1.12	1.12	0.28	1.12	0.56	0.56	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	93.15	3.60	0.98	1.31	2.61	1.63	0.98	0.65	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	169.45	10.90	5.03	11.74	5.03	5.87	8.39	6.71	2.52	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	122.46	4.77	1.91	0.64	0.95	0.64	0.95	0.32	0.32	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	95.45	3.40	0.68	1.36	1.02	0.34	0.34	0.68	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	121.11	4.18	0.00	2.09	4.18	2.09	0.00	0.00	0.00	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	96.21	1.15	1.72	0.57	0.57	1.15	1.72	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	43.51	2.07	1.18	1.48	1.18	0.30	0.89	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	91.48	5.08	0.00	6.78	1.69	5.08	1.69	8.47	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	118.05	4.97	0.83	1.66	2.07	0.41	1.66	0.41	1.24	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	101.26	3.45	0.69	1.15	1.38	0.69	1.84	1.61	0.69	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	121.18	10.54	0.00	0.00	0.00	5.27	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	100.33	3.46	1.54	2.31	0.38	0.38	0.77	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	90.62	4.24	0.98	0.00	0.33	0.33	0.98	0.65	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	68.22	2.01	1.34	2.01	0.00	0.67	0.67	0.00	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	142.16	3.85	0.77	1.93	1.93	0.00	1.16	0.00	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	160.56	11.30	0.68	4.11	4.45	1.71	2.40	1.03	0.68	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	129.21	17.39	2.48	7.45	2.48	4.97	0.00	4.97	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	136.84	9.44	4.25	1.42	1.89	1.42	1.42	1.42	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	104.40	7.85	4.22	2.41	0.60	0.60	1.81	1.21	0.60	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	111.91	4.07	4.07	1.02	0.00	0.00	1.02	2.54	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	143.98	9.57	3.19	1.99	1.99	0.40	1.99	0.40	1.99	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	169.22	6.41	5.92	3.45	1.97	0.99	1.48	0.49	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	246.71	10.62	4.72	0.00	1.18	1.18	1.18	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	119.61	3.50	3.50	4.08	1.75	0.00	1.17	2.92	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	146.15	7.02	3.07	1.76	2.19	0.88	1.76	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	89.01	11.02	4.24	1.70	0.85	0.85	0.85	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	99.68	4.18	2.39	2.39	0.00	0.60	1.79	0.00	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	81.04	4.37	0.97	1.94	1.94	0.97	0.00	0.49	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.52	0.83	1.66	0.83	0.42	0.42	0.00	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	42.82	3.81	0.95	0.63	0.63	0.63	1.27	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	0.42	0.00	0.42	0.42	0.00	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	91.56	2.09	0.46	0.70	0.58	0.58	0.58	0.58	0.35	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	114.45	2.87	0.34	1.18	1.69	1.18	1.01	0.84	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	99.65	2.05	0.46	0.68	0.46	0.91	1.59	2.05	0.46	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	92.37	3.06	1.53	1.20	1.75	0.66	0.55	0.87	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	101.22	2.36	0.64	1.50	0.00	0.64	0.43	0.64	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	94.08	1.51	0.86	1.94	0.86	0.65	0.43	1.51	0.22	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	75.84	2.12	0.37	0.62	0.50	0.62	1.00	0.62	0.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	76.51	1.89	0.86	1.03	0.69	0.17	1.20	0.51	0.00	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	68.88	0.32	0.00	0.64	0.32	0.32	0.64	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	0.00	0.00	0.00	0.00	2.64	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.21	0.17	0.00	0.00	0.17	0.35	0.35	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	55.69	3.63	1.21	1.21	2.42	0.00	2.42	0.00	1.21	1.21
Hepatocyte, donor2	11603-120I1	68.95	14.01	0.00	1.08	0.00	0.00	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	71.17	15.34	0.61	1.23	3.07	0.61	3.07	1.84	0.61	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	231.05	7.83	1.96	1.96	1.31	0.00	3.26	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	292.41	4.37	2.10	1.05	2.27	1.75	1.57	0.52	0.52	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	36.63	1.92	0.00	0.55	0.27	0.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	25.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	1.32	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	40.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	27.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	40.18	0.00	0.00	0.00	0.00	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	0.00	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	29.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	33.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	26.24	0.31	0.00	0.00	0.00	0.00	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	32.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	19.20	0.00	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	19.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	32.39	0.73	0.08	0.00	0.16	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	4.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	50.07	2.18	0.38	1.33	1.04	0.47	1.51	0.57	0.09	0.85
Keratinocyte - oral, donor1	11251-116E9	52.33	0.45	0.00	1.25	0.34	0.23	0.45	0.00	0.11	0.34
Keratocytes, donor1	11527-119I6	14.78	0.00	0.69	0.34	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	10.55	0.00	0.00	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	23.32	0.79	0.00	0.59	0.79	0.40	0.20	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	90.11	2.20	0.00	0.00	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	46.39	1.08	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	54.21	1.38	0.58	0.58	0.35	0.35	0.46	0.23	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	18.97	0.10	0.00	0.00	0.10	0.00	0.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.50	0.24	0.47	0.24	0.00	0.00	0.24	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.93	0.00	0.00	0.56	0.00	0.28	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	39.98	2.68	0.63	1.26	1.10	0.63	0.47	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.98	0.54	0.00	0.54	0.00	0.00	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.99	0.32	0.32	0.32	0.32	0.00	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.30	0.65	0.00	0.11	0.00	0.00	0.11	0.22	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	30.37	0.41	0.00	0.00	0.00	0.82	0.00	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.26	1.13	0.28	0.42	0.00	0.28	0.14	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	0.79	0.00	0.79	0.00	0.00	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	15.12	0.19	0.39	0.00	0.19	0.19	0.19	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.07	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.51	0.00	0.00	0.70	0.00	0.00	0.00	1.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.06	0.00	0.24	0.72	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.14	0.82	0.00	0.14	0.27	0.14	0.27	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	26.79	1.54	0.31	0.62	0.92	0.00	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.12	0.00	0.62	0.00	0.00	0.00	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.33	0.91	0.18	0.00	0.00	0.18	0.37	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.08	0.33	0.66	0.00	0.33	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.86	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	0.25	0.25	0.50	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	0.97	0.00	0.48	0.00	0.00	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.93	0.54	0.27	0.00	0.27	0.00	0.27	0.27	0.00	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.84	0.30	0.15	0.00	0.30	0.00	0.00	0.61	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	0.00	0.00	0.00	0.52	0.00	0.00	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.03	0.63	0.63	0.21	0.63	0.84	0.00	0.21	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.57	0.75	0.45	0.00	0.00	0.15	0.30	0.00	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	0.69	0.00	0.69	0.00	0.69	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.43	0.00	0.00	0.19	0.00	0.19	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.83	0.42	0.00	0.11	0.11	0.21	0.11	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.53	0.00	0.00	0.00	0.48	0.97	0.48	1.94	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.90	1.32	0.00	0.00	0.00	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.44	0.50	0.00	0.25	0.00	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.54	2.22	0.37	0.37	0.74	0.74	0.00	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.35	0.74	0.49	0.00	0.00	0.25	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.19	0.27	0.00	0.14	0.14	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.41	2.57	0.96	1.93	0.64	0.64	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.91	1.52	1.22	0.61	1.52	1.22	0.30	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.19	1.26	0.00	1.54	0.28	0.42	0.28	0.28	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	28.44	2.13	0.00	0.36	1.07	0.36	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.45	0.48	0.00	0.00	0.00	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.27	0.16	0.00	0.16	0.00	0.16	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.19	0.72	0.00	0.36	0.36	0.00	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.53	0.00	0.00	0.47	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.31	0.50	0.00	0.25	0.25	0.12	0.12	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.40	0.00	0.26	0.00	0.00	0.00	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	0.30	0.00	0.00	0.30	0.00	0.60	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	0.00	0.00	0.00	0.00	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.58	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.91	0.00	0.00	0.00	0.52	0.00	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.06	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	38.10	2.04	0.87	0.00	0.87	0.00	0.00	0.58	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.51	2.25	0.90	0.90	0.00	0.00	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.12	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.60	0.00	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	34.58	1.41	0.35	0.00	0.35	0.00	0.35	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	0.00	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	0.00	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	49.09	1.33	0.53	0.53	0.53	0.27	0.27	1.07	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	54.42	0.76	0.38	0.19	0.38	0.57	0.00	0.38	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	0.61	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	27.72	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	45.40	1.67	0.42	0.21	0.21	0.42	0.00	0.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.36	2.52	1.12	1.12	0.56	0.28	0.28	0.56	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	3.09	0.00	1.03	1.03	0.00	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	35.42	0.87	1.16	0.87	0.29	0.00	0.58	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	36.77	0.00	0.60	0.00	0.30	0.00	0.00	0.60	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	46.47	1.11	0.00	0.55	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.21	1.41	0.00	0.00	0.35	0.00	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.03	0.74	0.37	0.37	0.37	0.00	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	22.26	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.36	2.26	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	20.91	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.75	0.00	0.00	0.37	0.37	0.00	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.29	0.00	0.00	0.00	0.00	0.00	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	22.26	0.86	0.00	0.00	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.99	0.67	0.33	0.00	0.00	0.33	0.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	0.00	0.60	0.60	0.00	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.40	0.00	0.00	0.00	0.34	0.00	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.64	0.00	0.00	0.54	0.00	0.00	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	21.11	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	0.00	1.06	0.00	0.00	0.00	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.01	0.00	0.00	0.00	0.00	0.00	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	27.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	20.72	0.00	0.49	0.00	0.00	0.00	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	27.29	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.88	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	19.60	0.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	23.46	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	0.00	0.00	0.66	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.76	0.52	1.04	0.00	0.00	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	26.25	0.00	0.00	0.00	0.00	0.00	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.60	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.94	0.00	0.00	0.00	0.44	0.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.07	0.39	1.16	0.77	0.39	0.39	0.00	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	21.77	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.12	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	23.46	0.80	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	1.22	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.42	0.76	0.00	0.00	0.00	0.00	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.66	0.52	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	22.98	0.00	0.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.99	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.46	0.00	0.53	0.00	0.00	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	15.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	17.48	0.00	0.51	0.00	0.00	0.51	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.29	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	20.80	0.42	0.00	0.42	0.00	0.00	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.79	0.00	0.42	0.00	0.00	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	19.80	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	13.77	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	19.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	21.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	24.62	0.00	0.00	0.55	1.09	0.00	0.55	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	44.44	0.23	0.68	0.23	0.00	0.00	0.46	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	26.43	0.00	0.00	0.37	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	30.02	0.66	0.39	0.00	0.00	0.26	0.13	0.39	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	33.45	0.53	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	66.71	0.79	0.16	0.48	0.32	0.16	0.48	0.00	0.00	0.63
Mallassez-derived cells, donor3	11930-125I4	54.21	0.83	0.42	0.28	0.28	0.14	0.56	0.28	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	43.15	2.99	0.60	1.49	1.00	0.60	1.00	0.50	0.40	0.50
Mammary Epithelial Cell, donor2	11350-117G9	54.72	2.61	0.00	0.58	0.29	0.58	0.87	0.29	0.00	1.16
Mammary Epithelial Cell, donor3	11422-118F9	8.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	1560.61	0.68	0.00	0.00	0.00	0.00	0.68	0.00	1.36	0.68
Mast cell, donor1	11563-120D6	106.19	3.46	0.43	0.54	0.32	0.54	0.00	0.22	0.11	0.11
Mast cell, donor2	11565-120D8	117.98	2.08	0.59	0.30	0.59	0.30	0.00	0.30	0.00	0.30
Mast cell, donor3	11566-120D9	249.66	2.25	0.90	0.00	0.23	0.45	0.45	0.45	0.00	0.00
Mast cell, donor4	11567-120E1	94.14	0.71	0.89	0.00	0.00	0.18	0.18	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	130.08	2.11	0.89	0.89	1.66	1.44	0.44	0.67	0.22	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	90.47	0.00	0.58	1.17	0.58	0.00	1.17	0.00	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	101.99	0.34	1.15	0.92	0.34	0.23	0.11	0.34	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	118.16	1.34	0.84	0.67	0.33	0.50	0.00	0.00	0.50	0.67
Melanocyte - dark, donor1	11502-119F8	38.31	0.40	0.10	0.50	0.00	0.30	0.10	0.00	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	23.53	1.38	0.00	0.00	0.00	0.35	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	58.68	1.09	0.58	0.43	0.51	0.43	0.65	0.07	0.14	0.00
Melanocyte - light, donor1	11274-116H5	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.47	0.24	0.47
Melanocyte - light, donor2	11351-117H1	3.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	52.06	1.67	0.31	1.25	0.21	0.21	0.62	0.31	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	36.58	0.81	1.08	0.54	0.54	0.00	0.81	0.54	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	61.87	1.34	0.80	1.34	0.00	1.07	0.00	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	28.53	0.00	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	25.97	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	67.65	0.98	0.08	0.08	0.49	0.00	0.24	0.08	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.63	0.29	0.29	0.29	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	48.40	0.91	0.40	0.20	0.10	0.20	0.20	0.30	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.12	1.44	0.00	1.44	0.72	0.72	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	44.89	0.21	0.85	0.00	0.64	0.42	0.00	0.00	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.19	2.01	1.01	0.00	0.00	0.50	0.00	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.55	0.22	0.22	0.00	0.22	0.00	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.23	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	8.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	40.31	0.28	0.55	0.14	0.28	0.14	0.00	0.28	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.15	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.71	1.45	0.13	0.66	0.26	0.26	0.66	0.26	0.39	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	33.67	0.35	0.00	0.00	0.00	0.00	0.00	0.71	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	31.90	0.94	0.00	0.63	0.00	0.00	0.63	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.01	0.73	0.73	0.73	0.00	0.00	0.00	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	44.28	0.27	0.53	0.27	0.27	0.00	0.53	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	27.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	38.44	1.88	0.43	0.65	0.51	0.72	0.22	0.51	0.36	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	0.00	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.17	0.74	1.23	0.49	0.49	0.00	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.38	0.88	0.29	0.59	0.59	0.59	0.00	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	23.56	0.62	0.93	0.00	0.00	0.31	0.00	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	19.08	1.04	0.41	0.83	0.21	0.00	0.21	0.21	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.03	0.50	0.25	0.25	0.00	0.00	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	28.86	0.47	0.93	0.00	0.47	0.00	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	27.64	0.61	0.61	0.41	0.00	0.20	0.61	0.20	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.97	0.79	0.40	0.00	0.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.00	2.66	0.38	0.38	0.38	0.00	0.38	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	0.00	0.00	1.32	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.68	0.00	0.00	0.64	0.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.52	0.30	0.30	0.00	0.30	0.00	0.00	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.81	0.00	0.25	0.25	0.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.83	0.48	0.24	0.48	0.71	1.19	0.00	0.48	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.69	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	1.15	0.46	0.00	0.23	0.23	0.23	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.56	0.00	0.21	0.00	0.63	0.00	0.21	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.08	0.61	0.00	0.00	0.61	0.20	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.73	0.43	0.21	0.00	0.00	0.00	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.00	0.00	0.00	0.00	0.00	0.22	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.29	0.44	0.00	0.00	0.22	0.22	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.73	0.00	0.00	0.00	0.00	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.04	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	16.47	0.88	0.00	0.00	0.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	0.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.41	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	0.00	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.46	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	0.00	1.10	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.69	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.07	1.24	0.00	0.00	0.25	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.15	0.68	0.00	0.34	0.68	0.34	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.53	0.36	0.00	0.36	0.00	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.80	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.87	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	20.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.69	0.60	0.30	0.30	0.00	0.30	0.00	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.88	0.00	1.25	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	0.92	0.00	0.00	0.92	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	20.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.87	0.28	0.00	0.00	0.00	0.00	0.00	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	16.84	0.52	0.26	0.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.45	0.00	0.43	0.00	0.00	0.00	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	16.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.29	0.53	0.00	0.27	0.00	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.83	0.00	0.00	0.00	0.00	0.00	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	23.59	0.14	0.28	0.00	0.14	0.00	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.93	0.32	0.00	0.32	0.00	0.32	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.74	0.66	0.22	0.22	0.22	0.00	0.22	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	28.41	0.28	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	23.84	0.25	0.49	0.49	0.00	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	0.00	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.52	0.88	0.00	0.00	0.00	0.29	0.88	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	26.81	1.15	0.00	0.00	0.58	0.00	0.29	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	43.28	0.41	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.78	0.60	0.00	0.30	0.00	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	1.78	0.00	0.00	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.94	2.30	0.00	0.66	0.66	0.33	0.00	0.00	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	21.04	1.05	0.00	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.23	0.20	1.78	0.20	0.00	0.00	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	17.27	1.13	0.38	0.00	0.38	1.13	0.00	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.25	0.53	0.27	0.00	0.00	0.00	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	29.41	0.00	0.00	0.11	0.23	0.00	0.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	6.63	0.74	0.00	0.00	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.62	0.37	0.00	0.37	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	6.22	0.00	1.56	1.56	1.56	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	35.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	19.82	0.84	0.00	0.00	0.42	0.00	0.00	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	58.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	26.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	34.74	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	262.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	189.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	66.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	42.44	0.43	0.00	0.43	0.43	0.00	0.43	0.00	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	58.01	3.14	1.05	0.52	1.57	0.00	0.00	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	2.67	0.00	0.00	0.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	0.00	0.00	0.83	0.00	0.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	69.78	1.52	0.19	0.19	0.00	0.95	0.19	0.57	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	86.18	0.00	0.00	0.00	1.60	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	15.64	0.00	0.00	0.00	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	271.97	9.19	0.00	7.35	3.68	0.00	3.68	3.68	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.09	0.84	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.06	0.23	0.23	0.23	0.46	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	26.75	0.81	0.00	0.00	0.27	0.00	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	64.12	1.89	2.10	0.42	0.84	0.42	0.42	0.21	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2048.79	0.00	0.00	11.13	22.27	22.27	11.13	0.00	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	32.76	1.49	0.50	0.50	0.00	0.00	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.10	0.27	0.27	0.54	0.81	0.00	0.00	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.31	0.45	0.23	0.00	0.00	0.23	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.45	1.14	0.00	0.00	0.16	0.16	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	70.71	1.28	1.09	0.91	0.18	0.36	0.00	0.55	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	29.17	1.59	0.00	0.00	0.53	0.53	0.00	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.21	0.60	0.00	0.00	0.00	0.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	75.15	1.64	0.33	1.31	2.95	1.64	0.33	1.97	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.51	1.30	0.00	0.00	0.00	0.00	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	86.96	3.70	1.06	0.71	0.71	0.71	0.53	0.35	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	19.69	2.11	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	27.12	0.00	0.46	0.00	0.00	0.46	0.00	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.39	1.29	0.00	0.32	0.00	0.00	0.00	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	60.36	2.07	1.38	0.69	0.34	0.34	0.34	0.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	450.06	2.53	0.00	0.00	5.06	5.06	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.90	2.01	0.45	0.45	0.45	0.45	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.90	0.85	0.42	0.00	0.00	0.42	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	27.30	1.19	0.00	0.00	0.24	0.24	0.00	0.24	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.60	0.86	0.43	0.00	0.00	0.00	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2410.41	36.11	9.03	0.00	27.08	0.00	18.06	9.03	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.33	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	35.62	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	0.40	0.00	0.40	0.00	0.00	0.00	0.79	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	30.65	0.00	0.00	0.00	0.00	0.00	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.24	0.76	0.00	0.38	0.38	0.38	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.23	1.30	0.00	0.33	0.00	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	25.28	0.87	0.00	0.00	0.00	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	87.74	0.90	0.45	0.00	0.00	0.45	0.00	0.00	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	0.00	0.00	0.00	0.66	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	1.49	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.29	0.38	0.00	0.00	0.00	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	49.90	0.91	0.00	0.30	0.91	0.00	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	60.34	2.21	0.22	0.00	0.00	0.00	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	0.68	0.68	0.00	0.00	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	674.46	5.11	0.00	20.44	0.00	5.11	5.11	5.11	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.07	0.00	0.00	0.00	0.00	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.72	0.63	0.63	0.31	0.00	0.00	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	2.12	0.30	0.00	0.00	0.00	0.00	0.30	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.06	1.58	0.00	0.79	0.00	0.00	0.00	0.00	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	79.36	1.13	1.13	1.13	0.00	0.00	0.00	5.67	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	490.62	15.17	0.00	0.00	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	54.91	0.75	0.99	0.12	0.37	0.50	0.50	0.12	0.12	0.12
Myoblast, donor2	11322-117D8	60.80	5.18	1.34	0.19	1.15	0.96	0.19	0.00	0.00	0.38
Myoblast, donor3	11398-118D3	67.10	0.17	0.34	0.67	0.00	0.00	0.17	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	144.18	11.38	2.19	1.46	2.63	1.75	2.33	2.19	1.02	1.17
Natural Killer Cells, donor1	11230-116C6	119.93	2.46	0.92	1.23	0.62	0.31	0.31	0.00	0.31	1.54
Natural Killer Cells, donor2	11311-117C6	104.34	3.92	3.02	1.51	1.81	0.30	0.30	1.21	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	117.98	5.34	1.47	1.66	1.66	0.55	1.66	0.74	0.37	0.92
Neural stem cells, donor1	11275-116H6	215.22	3.27	0.73	0.00	0.00	0.36	0.36	0.73	1.09	0.00
Neural stem cells, donor2	11352-117H2	308.10	0.00	0.00	1.93	0.00	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	92.17	14.79	1.14	3.41	1.14	0.00	1.14	0.00	0.00	1.14
Neurons, donor2	11574-120E8	115.15	1.54	0.66	0.44	0.22	0.00	0.66	0.22	0.44	0.44
Neurons, donor3	11655-122E8	89.62	18.09	1.64	1.64	2.47	2.47	0.00	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	47.33	0.93	0.00	0.93	0.93	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	43.48	5.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	59.86	0.61	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	44.76	0.47	0.24	1.31	0.36	0.36	0.47	0.00	0.00	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	19.54	0.00	0.00	0.33	0.00	0.00	0.00	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	19.45	0.20	0.20	0.00	0.00	0.00	0.20	0.00	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	33.59	3.99	0.96	0.83	0.69	0.41	0.41	0.28	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	42.84	3.47	1.30	1.16	1.74	1.16	0.58	0.00	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	45.06	2.95	1.25	0.45	1.02	0.34	0.68	0.34	0.45	0.45
Olfactory epithelial cells, donor4	11936-126A1	39.74	1.36	0.39	0.49	0.58	0.58	0.58	0.19	0.29	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	50.55	1.81	0.00	0.60	0.60	0.60	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	16.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.86	1.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	4.50	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	64.61	2.81	0.00	0.70	1.40	0.00	0.00	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	15.64	0.18	0.18	0.00	0.00	0.18	0.18	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	75.22	1.52	0.25	1.18	0.51	0.59	0.42	0.17	0.25	0.51
Pericytes, donor1	11491-119E6	6.01	0.00	0.22	0.00	0.11	0.11	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	5.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.92	0.20	0.20	0.20	0.00	0.00	0.00	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	61.71	1.13	0.90	1.02	0.45	0.45	0.68	0.00	0.23	0.23
Perineurial Cells, donor2	11579-120F4	35.15	0.00	0.09	0.28	0.09	0.00	0.18	0.09	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	194.11	3.19	0.00	1.59	1.27	0.64	0.64	0.00	0.32	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	85.46	3.43	2.94	0.24	0.00	0.00	0.49	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	97.19	1.94	0.52	0.52	0.13	0.52	0.26	0.26	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	9.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	0.00	1.11	0.00	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.17	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	42.21	0.75	0.56	0.38	0.00	0.19	0.00	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	128.83	1.04	2.74	0.13	0.26	0.26	1.04	0.26	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	42.10	1.13	1.13	0.23	0.00	0.00	0.00	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	45.18	1.28	1.07	0.32	0.00	0.21	0.21	0.00	0.21	0.00
Preadipocyte - omental, donor2	11329-117E6	48.88	0.44	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	34.38	3.44	0.29	0.57	1.00	0.43	0.14	0.72	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	59.50	4.60	0.89	1.24	1.06	0.71	0.35	0.18	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	35.42	0.34	0.51	0.17	0.17	0.00	0.51	0.00	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	65.02	3.26	0.65	0.37	0.37	0.47	0.09	0.47	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	47.40	3.22	0.92	0.00	0.46	0.00	0.46	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	35.53	1.15	0.73	0.21	0.52	0.10	0.10	0.42	0.21	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	192.79	6.03	1.81	4.07	2.56	3.32	2.56	0.75	1.21	1.81
Prostate Epithelial Cells, donor2	11331-117E8	32.91	0.54	0.41	0.27	0.14	0.41	0.00	0.14	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	48.01	2.39	0.31	1.10	0.98	1.65	0.43	0.61	0.31	0.18
Prostate Stromal Cells, donor1	11254-116F3	44.65	1.14	0.11	1.03	0.23	0.23	0.00	0.00	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	48.77	2.33	0.90	1.43	0.72	0.54	0.54	0.54	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	38.27	1.36	0.10	0.73	0.94	0.31	0.52	0.00	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.49	0.00	0.00	0.00	0.00	0.00	0.00	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.35	0.49	0.21	0.42	0.55	0.14	0.49	0.07	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	48.27	0.85	0.42	0.53	0.32	0.32	0.53	0.00	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.16	0.13	0.67	0.00	0.13	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.53	1.78	0.00	0.67	0.22	0.22	0.44	0.44	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.46	0.22	0.00	0.44	0.00	0.00	0.22	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	13.17	0.00	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.69	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.70	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.73	0.19	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.78	1.04	0.00	0.78	1.04	0.26	1.56	0.26	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.48	0.28	0.00	0.28	0.28	0.00	0.00	0.00	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	46.42	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	114.66	1.74	1.07	1.74	0.40	0.13	0.53	0.27	0.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	74.15	1.79	0.89	0.89	0.89	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	210.79	11.01	2.20	7.71	5.50	2.75	3.30	2.20	2.20	5.50
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	446.64	8.70	0.00	4.06	4.06	1.16	1.74	1.16	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	131.20	0.13	0.91	0.39	0.26	0.00	0.13	0.13	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	67.23	4.87	0.89	1.59	1.29	0.89	0.70	0.60	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	90.57	1.23	0.67	0.78	1.00	0.33	0.89	0.22	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	126.03	4.71	1.49	1.12	1.36	0.50	1.24	0.37	0.37	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	72.96	5.13	1.05	0.93	1.05	1.40	1.40	0.47	0.70	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	108.17	10.63	0.69	3.93	2.08	2.08	3.70	0.46	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	75.57	1.37	1.23	1.23	0.96	0.41	0.27	0.55	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	80.48	3.93	0.45	1.21	2.12	0.45	1.36	0.91	0.76	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	65.76	0.18	0.72	0.36	0.00	0.00	0.18	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	68.29	1.86	2.01	0.86	0.57	0.43	0.86	0.43	0.00	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	67.72	1.93	0.64	0.64	0.54	0.43	0.32	0.11	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	74.57	4.65	1.11	2.43	1.55	0.22	1.77	1.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	71.88	0.38	0.96	0.19	0.38	0.57	0.38	0.38	0.57	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	69.87	3.07	0.75	0.56	0.65	0.37	0.47	0.28	0.09	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	123.83	3.01	0.56	2.82	1.69	1.13	0.94	0.56	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	72.19	1.19	1.33	0.27	0.80	0.66	0.66	0.40	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	88.39	3.60	0.49	1.36	1.75	1.27	1.17	0.49	0.29	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	74.28	7.07	0.76	2.48	0.57	0.95	3.25	1.53	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	66.85	0.96	1.17	0.96	0.11	0.21	0.21	0.32	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	68.96	2.80	1.12	1.68	0.28	0.84	1.12	0.56	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	81.86	7.69	1.71	1.88	1.88	0.85	1.71	1.03	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	59.80	0.91	1.46	0.55	0.18	0.18	0.55	0.36	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	64.26	3.07	0.37	1.35	0.86	0.49	0.74	0.25	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	86.10	3.49	0.27	1.88	0.81	0.67	0.94	0.81	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	82.08	1.42	1.65	0.71	0.47	0.00	0.00	0.94	0.24	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	61.90	4.76	1.19	2.38	0.60	1.19	0.60	0.60	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	65.01	4.21	0.70	1.40	0.70	0.70	1.17	0.23	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	63.04	1.45	1.04	0.83	0.62	0.00	0.21	0.41	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	64.15	2.88	0.66	0.66	0.44	0.00	0.44	0.44	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	66.84	5.64	0.84	1.25	0.84	0.21	1.25	0.84	0.21	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	78.33	2.42	1.48	1.21	0.94	0.00	0.54	0.54	0.13	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	64.03	2.21	0.34	0.68	0.68	1.02	0.00	0.17	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	80.59	8.29	0.58	2.31	0.96	1.35	1.16	1.16	0.19	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	88.03	2.92	1.72	0.69	1.55	0.34	0.34	0.86	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	60.22	1.78	0.55	0.96	0.96	0.27	0.41	0.55	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	96.04	6.40	0.33	2.79	1.15	1.31	1.15	0.99	0.49	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	75.16	0.68	0.51	0.85	0.85	0.34	0.00	0.34	0.17	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	73.98	6.51	1.18	1.92	3.26	0.74	1.78	0.89	0.44	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	85.56	3.20	0.80	1.33	1.33	0.53	1.07	0.00	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	68.72	1.52	1.24	0.41	0.69	0.28	0.28	0.69	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.72	3.33	0.71	0.95	0.71	0.71	2.14	0.48	0.48	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	119.72	4.64	0.40	2.02	1.21	1.01	0.60	0.81	0.20	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	67.81	1.79	1.22	0.57	0.19	0.38	0.00	0.19	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	78.61	17.47	1.40	4.19	1.75	1.40	3.84	1.75	0.00	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	81.30	2.42	0.30	1.21	1.51	0.91	0.30	0.30	0.60	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	67.44	2.08	1.47	0.12	0.73	0.24	0.49	0.12	0.00	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	212.22	2.18	1.16	1.16	0.44	0.15	0.87	1.02	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	94.31	3.04	0.00	0.61	0.00	1.22	0.61	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	77.16	0.30	1.81	0.60	0.60	0.00	0.00	0.60	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	63.11	5.65	0.90	0.90	1.13	0.68	0.45	0.68	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	115.62	6.29	0.60	1.50	1.80	1.80	2.10	0.30	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	81.00	0.94	0.71	0.59	0.59	0.12	0.12	0.12	0.12	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	52.29	1.92	0.21	0.00	0.00	0.00	0.00	0.43	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	99.16	6.61	0.00	0.00	0.00	0.00	0.00	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	11.10	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.19	0.88	0.44	0.66	0.22	0.00	0.00	0.66	0.44	0.22
Sebocyte, donor1	11220-116B5	25.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	17.46	0.46	0.00	0.00	0.46	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	9.28	0.21	0.21	0.00	0.00	0.00	0.00	0.00	0.21	0.00
Sertoli Cells, donor1	11255-116F4	51.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	81.91	0.00	2.82	0.00	0.00	0.00	0.00	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	58.33	1.14	0.09	0.44	0.26	0.18	0.18	0.26	0.09	0.00
Skeletal Muscle Cells, donor2	11358-117H8	7.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	58.60	0.47	2.36	0.00	0.00	0.00	0.00	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	49.65	0.89	2.53	0.00	0.15	0.15	0.15	0.00	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	63.25	0.92	2.31	0.15	0.00	0.15	0.62	0.15	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	124.24	2.65	1.13	1.76	1.13	0.88	1.26	0.25	0.13	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	77.91	2.57	1.71	1.14	0.57	0.29	1.43	0.14	0.29	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	72.03	2.28	0.20	0.60	0.50	0.89	0.30	0.20	0.00	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	48.11	0.59	0.67	0.67	0.17	0.08	0.08	0.08	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	201.46	64.47	2.69	0.00	8.06	0.00	0.00	13.43	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.96	0.14	0.00	0.14	0.00	0.29	0.00	0.00	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	444.11	0.82	2.45	0.00	0.00	0.00	0.00	0.82	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.50	0.26	0.00	0.13	0.26	0.00	0.00	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	45.32	0.42	0.83	0.56	0.00	0.14	0.42	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	42.62	1.69	0.42	0.28	0.42	0.00	0.00	0.28	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	443.82	9.30	1.90	2.11	1.48	1.06	1.48	1.48	0.63	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	57.26	1.72	0.22	0.90	0.75	0.37	0.60	0.07	0.45	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.64	0.00	0.00	0.31	0.31	0.00	0.00	0.31	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	89.60	1.33	1.33	0.00	1.56	0.22	0.44	0.67	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.18	0.22	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	56.04	0.00	0.00	2.00	0.00	0.00	2.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.19	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.67	8.20	1.99	1.55	0.66	0.89	1.33	1.11	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.03	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	48.51	0.65	1.30	0.33	0.00	0.00	0.98	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	47.84	1.48	0.00	0.59	0.30	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	27.05	0.85	0.14	0.43	0.14	0.00	0.28	0.28	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.60	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.31	2.13	0.00	0.61	0.91	0.30	0.00	0.00	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.84	0.25	0.00	0.00	0.25	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	48.08	0.44	0.74	0.29	0.00	0.15	0.15	0.15	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	44.12	1.94	0.65	0.22	0.22	0.00	0.43	0.22	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	45.13	1.47	0.42	0.10	0.10	0.10	0.10	0.10	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.16	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.46	0.34	0.00	0.34	0.00	0.00	0.34	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	77.27	1.81	0.79	2.12	0.63	0.39	1.26	0.63	0.00	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	55.65	0.91	0.50	0.00	0.10	0.00	0.10	0.20	0.30	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	36.41	0.46	1.82	0.46	0.00	0.23	0.46	0.00	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	81.86	3.18	0.26	1.06	0.26	0.79	0.79	0.53	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	58.32	0.67	1.60	0.67	0.00	0.00	0.00	0.00	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.20	2.50	1.50	1.00	0.25	0.63	0.13	0.00	0.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.37	0.25	0.51	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.71	0.15	0.15	0.15	0.00	0.00	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	0.00	0.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	0.00	1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	18.68	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	53.82	0.42	0.08	0.00	0.08	0.08	0.17	0.00	0.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.09	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.48	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	0.25	0.25	0.25	0.00	0.00	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	46.53	1.12	0.42	0.14	0.28	0.00	0.14	0.28	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	19.02	0.00	0.00	0.08	0.08	0.00	0.00	0.00	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.20	0.88	0.66	0.22	0.44	0.00	0.00	0.22	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	30.72	1.17	0.29	0.00	0.00	0.29	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	54.42	1.55	0.00	0.19	0.58	0.19	0.39	0.39	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	33.06	2.38	0.00	0.26	0.26	0.00	0.26	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	73.65	3.35	0.37	1.12	0.37	0.74	0.74	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	54.98	1.44	0.36	0.00	0.72	1.08	0.00	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.00	0.57	0.00	0.00	0.00	0.57	0.00	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	57.50	4.73	0.39	0.79	0.00	0.00	0.00	0.39	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	53.84	2.03	0.51	0.51	0.00	0.00	0.00	0.76	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	48.72	3.99	1.20	1.20	0.80	0.80	0.00	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	27.59	0.84	1.25	0.42	0.42	0.00	0.42	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	43.54	1.38	0.46	0.00	0.00	0.46	0.92	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	40.40	1.51	0.50	1.18	1.18	0.50	0.17	0.00	0.17	0.00
Synoviocyte, donor2	11368-117I9	35.03	3.18	1.01	1.17	0.34	0.34	0.84	0.84	0.17	0.67
Synoviocyte, donor3	11440-118H9	38.43	5.14	1.34	0.45	0.22	0.45	0.22	0.45	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	16.08	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.41	0.00	0.22	0.07	0.07	0.00	0.00	0.07	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.89	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	117.00	2.58	1.72	1.23	0.74	0.49	1.35	0.12	0.49	0.37
Urethra, donor2	10319-105A4	116.90	53.95	1.80	0.00	1.80	0.00	1.80	7.19	1.80	0.00
Urothelial Cells, donor1	11520-119H8	2.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	24.07	0.45	0.67	0.22	0.22	0.45	0.22	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	142.37	0.00	1.78	0.89	0.00	0.00	0.00	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	152.97	2.86	2.86	0.00	1.43	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	97.89	2.74	2.74	0.68	0.00	0.68	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	126.72	2.07	3.79	0.69	0.00	0.34	0.34	0.69	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	123.18	1.74	1.74	1.16	0.00	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	128.07	0.00	3.12	0.00	1.04	0.00	0.00	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	172.54	1.84	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	97.68	3.65	7.30	0.00	0.00	0.00	0.91	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	75.13	3.82	0.99	1.11	0.99	0.99	0.37	0.62	0.37	0.25
Wilms' tumor cell line:HFWT	10597-108E3	49.28	3.52	0.00	0.88	1.76	0.00	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	63.41	3.91	0.56	1.40	1.96	1.12	0.56	0.56	0.84	0.00
achilles tendon, donor2	10292-104G4	59.93	123.99	0.00	0.00	0.00	2.07	2.07	6.20	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	131.81	13.51	1.53	2.29	2.04	2.04	1.02	1.27	0.25	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	176.68	8.36	2.32	1.39	2.09	0.70	1.63	0.70	0.46	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	321.70	10.80	2.97	2.49	1.90	1.90	0.95	0.71	0.59	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	154.83	16.33	0.54	2.99	2.99	2.18	1.90	1.63	1.09	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	150.94	6.75	2.25	3.37	3.09	2.25	1.97	1.69	0.84	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	163.47	0.21	2.54	0.63	0.21	0.63	0.21	0.00	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	78.12	5.17	1.09	0.00	0.27	0.82	0.27	1.63	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	216.79	10.58	3.97	1.32	2.20	2.64	2.20	1.76	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	223.78	15.93	6.13	1.23	3.27	1.23	0.82	1.63	2.45	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	139.40	13.20	4.66	3.11	1.16	2.33	1.55	3.11	0.78	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	138.37	7.18	0.55	1.47	2.76	1.47	1.47	1.47	0.55	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	354.95	39.01	3.90	0.00	0.00	3.90	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	127.81	5.58	0.23	2.09	3.02	1.16	1.16	0.46	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	193.92	8.80	1.04	1.29	3.37	0.78	1.55	1.81	0.78	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	156.94	10.23	1.75	3.80	4.38	2.92	0.88	2.63	0.58	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	130.60	5.11	0.93	0.46	1.39	0.46	0.00	0.93	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	100.35	3.29	2.06	0.00	0.82	0.00	0.00	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	24.86	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	99.85	2.13	0.43	2.13	0.85	0.00	1.71	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	119.80	1.82	0.61	0.30	0.30	0.00	0.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	119.15	2.17	0.48	0.24	0.48	0.24	0.24	0.24	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	94.89	3.56	0.45	1.11	2.45	0.45	0.89	0.89	0.67	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	125.08	2.33	0.00	0.67	0.67	0.00	0.33	0.33	0.33	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	165.38	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	134.84	4.14	1.88	0.75	1.13	1.13	0.75	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	244.23	4.80	2.18	1.31	1.31	1.74	0.44	0.44	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	174.33	1.87	0.00	0.00	3.75	3.75	7.50	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	46.16	0.94	0.00	0.94	0.47	0.47	0.47	0.71	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	58.48	1.55	0.31	0.62	0.00	0.16	0.00	0.00	0.31	0.16
adipose, donor1	10184-103D4	512.52	32.84	7.62	18.77	13.49	7.04	12.31	7.04	2.93	4.10
adipose, donor2	10185-103D5	64.88	4.87	2.03	0.81	1.62	0.81	0.81	0.41	0.41	0.00
adipose, donor3	10186-103D6	105.65	11.16	2.18	3.81	2.45	2.18	3.54	1.91	1.91	0.54
adipose, donor4	10187-103D7	106.61	6.93	2.60	5.20	3.47	2.60	6.07	2.60	6.07	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	106.69	2.37	0.79	1.26	1.10	0.47	1.26	0.95	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	131.94	3.74	0.93	2.00	0.80	0.53	0.67	0.13	0.27	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	95.40	6.43	3.22	2.14	0.71	0.00	1.43	1.07	1.43	0.71
amniotic membrane cells, donor1	12235-129G3	36.17	0.46	0.00	0.46	0.70	0.23	0.23	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	58.83	1.35	0.68	0.00	0.34	0.00	0.00	0.00	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	53.91	1.77	0.59	1.18	0.00	0.00	0.00	0.00	0.00	0.29
amygdala - adult, donor10196	10167-103B5	202.77	8.30	2.37	0.00	2.37	5.93	1.19	3.56	1.19	1.19
amygdala, adult, donor10252	10151-102I7	259.95	27.37	3.45	3.85	4.66	4.06	2.43	2.03	4.46	0.61
amygdala, newborn, donor10223	10360-105E9	83.27	6.13	1.29	1.29	1.94	0.97	1.29	1.94	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	106.45	1.40	0.38	0.51	0.25	0.51	0.25	0.13	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	69.06	4.41	0.44	1.10	0.88	1.10	0.22	1.32	0.22	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	356.08	38.75	12.03	5.01	7.01	11.36	7.01	5.01	2.34	2.34
aorta, adult, pool1	10052-101G7	50.41	8.24	0.59	2.16	0.00	0.78	0.39	0.20	0.20	0.59
appendix, adult	10189-103D9	180.86	3.10	2.33	0.78	1.55	0.39	0.00	0.78	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	242.82	13.76	3.10	3.10	4.47	2.06	1.03	1.38	0.34	0.69
artery, adult	10190-103E1	108.70	5.43	2.72	0.00	0.00	0.00	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	107.20	3.04	0.87	0.58	0.43	0.29	0.29	0.72	0.29	0.00
b cell line:RPMI1788	10427-106D4	133.98	2.97	1.19	1.04	1.64	0.45	0.45	0.45	0.30	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.66	0.00	0.00	0.28	0.00	0.00	0.83	0.00	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	98.54	0.99	0.40	0.30	0.50	0.40	0.20	0.20	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	75.32	2.51	1.51	0.50	0.50	0.50	0.50	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	71.02	3.36	3.36	0.56	1.12	0.56	1.68	0.56	1.12	0.00
bladder, adult, pool1	10011-101C2	98.10	1.85	0.43	0.87	0.43	0.33	0.33	0.43	0.33	0.00
blood, adult, pool1	10053-101G8	37.65	4.43	2.21	0.00	0.00	0.00	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	96.77	0.00	0.00	0.00	0.00	0.00	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	101.90	14.17	2.02	2.02	4.05	1.35	0.67	2.70	0.00	1.35
brain, adult, donor1	10084-102B3	18.45	7.18	0.00	0.00	1.03	0.00	0.00	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	83.74	3.01	0.67	1.00	1.22	0.67	1.11	0.33	0.56	0.45
brain, fetal, pool1	10085-102B4	48.09	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	143.38	7.60	0.00	1.65	1.98	2.31	0.66	2.64	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	350.13	3.50	1.62	2.75	1.50	0.75	1.12	0.37	0.62	0.37
breast, adult, donor1	10080-102A8	42.30	3.79	0.00	0.63	0.63	0.00	0.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	62.88	7.37	1.14	0.76	1.65	1.52	0.51	0.64	0.25	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	120.91	16.70	4.02	0.62	2.78	1.24	0.93	2.16	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	162.77	4.83	3.68	1.38	1.38	1.38	1.15	1.38	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	63.18	3.15	2.42	1.21	1.94	1.45	1.21	0.48	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	158.92	12.69	8.93	1.88	1.41	1.41	2.82	1.88	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	106.97	1.09	0.00	0.88	0.88	1.09	1.09	0.33	0.77	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	160.67	20.28	9.82	1.27	2.85	1.58	0.32	2.54	1.27	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	296.79	11.71	2.66	6.92	7.19	3.73	4.79	2.66	1.86	2.66
caudate nucleus - adult, donor10196	10177-103C6	276.32	17.27	2.30	1.15	1.15	3.45	0.00	4.61	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	241.45	17.74	2.18	5.69	5.52	4.35	4.18	1.00	1.84	1.84
caudate nucleus, adult, donor10258	10379-105H1	116.91	7.64	0.00	4.58	2.29	3.06	2.29	3.82	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	105.48	10.25	1.83	2.20	1.83	2.20	0.37	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	1013.82	29.13	5.83	0.00	8.74	0.00	5.83	11.65	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	839.95	53.38	4.91	20.92	13.45	16.23	8.54	6.83	16.44	3.42
cerebellum, adult, pool1	10083-102B2	145.22	14.14	4.14	4.83	2.07	2.07	3.79	2.41	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	543.01	78.88	1.66	21.59	18.27	15.78	13.28	8.30	4.15	9.13
cerebral meninges, adult	10188-103D8	70.60	2.52	1.26	0.00	0.00	0.00	0.25	0.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	59.93	14.62	1.46	1.46	2.19	0.00	0.00	2.19	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	218.55	4.46	3.88	2.16	1.58	0.86	0.86	0.58	0.14	0.58
cervical cancer cell line:ME-180	10553-107I4	101.75	2.32	1.49	1.82	0.66	0.83	0.50	0.00	0.17	0.00
cervix, adult, pool1	10013-101C4	160.95	4.62	1.15	2.41	1.78	1.05	0.73	0.42	1.36	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	81.23	0.98	2.65	0.14	0.28	0.28	0.28	0.28	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	27.43	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	128.50	2.36	0.99	1.12	0.75	0.25	0.87	0.50	0.25	0.37
choriocarcinoma cell line:SCH	10785-110H2	67.03	3.33	0.74	1.11	0.99	0.99	0.49	0.12	0.25	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	101.28	2.37	0.95	0.47	0.47	0.24	0.47	0.24	0.47	0.71
chorionic membrane cells, donor1	12238-129G6	33.05	0.00	0.57	0.00	0.00	0.00	0.28	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	53.69	0.00	0.20	0.30	0.20	0.10	0.20	0.20	0.00	0.10
chorionic membrane cells, donor3	12240-129G8	51.65	0.55	1.10	0.55	0.00	0.00	0.00	1.10	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	95.93	5.05	2.02	3.03	1.01	3.03	1.01	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	79.91	4.61	1.34	0.77	0.58	0.96	0.77	0.96	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	117.21	4.22	0.84	0.21	0.42	0.84	0.42	0.84	0.21	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	173.60	6.68	0.51	1.03	1.28	0.77	1.28	0.77	0.77	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	174.88	4.60	0.48	1.45	1.21	0.48	1.21	0.97	1.21	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	212.98	7.74	1.22	2.85	1.63	1.02	0.41	0.20	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	172.85	7.07	4.12	1.77	0.88	2.06	2.36	2.06	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	291.64	3.91	1.30	1.30	1.82	2.35	0.52	0.78	0.26	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	153.61	6.86	4.80	2.29	1.83	1.60	2.29	1.60	0.46	0.69
clear cell carcinoma cell line:TEN	10636-108I6	114.51	1.74	0.69	0.35	0.35	0.17	0.69	0.35	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	180.30	2.93	1.65	0.73	0.37	0.18	0.18	0.37	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	469.40	10.26	0.76	1.90	2.28	0.76	1.14	0.38	0.38	1.14
colon, adult, donor1	10082-102B1	35.70	2.38	0.00	0.00	1.19	2.38	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	94.36	1.06	0.94	0.71	0.71	0.59	0.00	0.35	0.00	0.59
colon, fetal, donor1	10070-101I7	90.84	6.18	3.71	0.62	0.62	2.47	1.85	0.00	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	1375.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	166.15	4.25	1.27	0.00	0.42	0.42	0.00	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	113.95	2.11	2.26	0.30	0.00	0.45	0.30	0.30	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	135.65	3.53	2.12	0.56	0.85	0.14	0.14	0.28	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	108.90	2.87	0.44	2.10	1.22	1.55	0.33	0.22	1.00	0.66
cruciate ligament, donor2	10295-104G7	98.88	42.14	0.00	1.62	3.24	0.81	0.00	2.43	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	63.40	9.63	1.61	4.01	1.61	3.21	2.41	1.61	0.00	0.80
diencephalon, adult	10193-103E4	98.88	6.00	2.40	1.20	1.20	0.72	0.96	1.44	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	160.50	16.76	3.67	1.84	5.05	2.76	2.76	2.76	1.38	2.53
ductal cell carcinoma cell line:KLM-1	10438-106E6	128.48	1.54	0.51	0.26	0.26	0.26	0.00	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	76.55	5.54	0.96	1.44	0.72	1.44	1.20	0.48	0.00	0.96
ductus deferens, adult	10196-103E7	135.05	8.47	3.99	3.99	1.50	1.50	1.00	1.00	1.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	96.50	14.40	4.32	2.88	4.32	0.00	2.88	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	223.64	13.24	5.89	3.68	3.68	4.41	2.94	8.83	0.74	1.47
dura mater, adult, donor1	10041-101F5	88.86	2.15	0.58	0.74	0.74	0.25	0.17	0.00	0.08	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	124.58	0.89	0.67	0.22	0.22	0.00	0.00	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	137.71	2.58	1.00	0.29	0.00	0.29	0.43	0.72	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	82.01	3.08	1.23	0.62	1.85	0.00	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	77.19	1.82	0.00	0.61	0.61	1.21	0.30	0.61	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	98.18	1.54	0.62	0.31	0.93	0.31	0.62	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	89.32	1.31	0.00	0.00	0.00	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	183.02	4.36	0.00	0.67	0.00	0.67	0.34	0.67	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	89.71	7.43	1.63	2.54	1.81	1.81	1.81	0.36	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	41.97	3.22	0.64	0.32	0.48	0.64	0.48	0.80	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	103.38	0.67	0.44	0.44	0.22	0.22	0.22	0.44	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	91.73	1.43	0.66	0.44	0.77	0.55	0.55	0.11	0.11	0.33
epididymis, adult	10197-103E8	106.96	3.56	2.09	0.21	0.42	0.42	0.42	1.88	1.05	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	59.79	5.68	0.71	1.24	0.89	1.24	0.18	0.89	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	52.69	1.18	0.00	0.00	0.79	0.39	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	173.64	12.84	1.70	3.41	2.10	1.44	1.97	1.57	0.13	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	228.33	12.70	1.57	1.97	2.76	2.07	1.18	1.28	0.49	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	143.17	9.07	1.68	3.81	1.46	1.57	2.46	1.01	0.34	0.78
esophagus, adult, pool1	10015-101C6	57.87	1.17	0.11	0.53	0.00	0.42	0.32	0.00	0.42	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	251.47	1.88	1.00	2.00	1.75	1.13	0.75	0.50	0.50	0.13
eye - muscle inferior rectus, donor1	10272-104E2	166.61	96.58	4.83	2.41	2.41	0.00	2.41	4.83	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	98.90	35.77	2.10	2.10	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	116.08	32.74	1.49	0.00	4.46	0.00	0.00	2.98	4.46	1.49
eye - muscle superior, donor2	10297-104G9	129.55	27.52	2.29	0.00	1.15	0.00	1.15	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	139.91	17.49	0.00	1.46	2.91	2.91	0.00	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	66.61	4.32	0.51	1.02	1.78	0.76	0.00	1.02	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	56.93	4.23	0.64	1.54	0.38	1.15	0.64	0.26	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	92.36	4.27	3.56	0.95	1.42	0.24	1.90	0.71	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	160.16	4.79	0.75	3.57	1.78	1.78	0.75	0.56	0.56	1.50
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	157.93	22.22	3.90	6.31	3.30	5.10	2.40	2.10	0.60	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	97.11	0.91	0.27	0.37	0.18	0.09	0.00	0.00	0.09	0.18
gall bladder, adult	10198-103E9	71.22	2.41	0.48	0.48	0.00	0.24	0.24	0.48	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	207.76	0.00	4.29	1.07	0.00	0.00	0.54	0.54	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	156.87	0.37	2.24	0.75	0.37	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	93.99	3.59	1.69	1.69	0.21	0.63	2.11	0.84	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	87.42	4.84	0.19	0.97	0.39	0.19	0.77	0.77	0.58	1.16
gastric cancer cell line:AZ521	10549-107H9	208.39	2.95	1.80	1.31	1.97	0.82	1.48	0.33	0.00	0.82
gastric cancer cell line:GSS	10560-108A2	95.18	1.83	0.00	0.92	0.92	2.75	0.00	0.00	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	159.23	8.68	1.60	3.43	2.74	3.43	2.06	1.60	0.91	1.14
giant cell carcinoma cell line:LU65	10487-107B1	55.88	3.10	0.92	0.23	0.46	0.46	0.00	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	108.05	1.40	0.84	0.42	0.14	0.70	0.42	0.00	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	135.68	4.24	1.50	1.25	1.50	0.75	1.25	1.00	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	107.56	2.11	0.74	0.84	0.84	0.74	0.95	0.63	0.63	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	106.31	3.09	1.12	1.83	1.54	1.26	0.42	0.56	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	133.99	5.74	2.21	2.10	1.21	0.33	0.66	1.21	0.33	0.33
glioma cell line:GI-1	10413-106B8	113.05	1.46	0.00	1.17	0.29	0.00	0.88	0.00	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	181.50	18.95	2.92	0.00	2.19	0.73	0.73	0.73	1.46	2.19
globus pallidus, adult, donor10252	10161-103A8	389.33	37.35	4.64	7.81	6.35	6.35	3.66	2.44	4.15	2.20
globus pallidus, adult, donor10258	10367-105F7	138.29	6.85	0.00	2.74	4.11	5.48	0.00	4.11	5.48	0.00
globus pallidus, newborn, donor10223	10364-105F4	70.35	2.13	1.07	1.07	0.53	0.00	0.53	1.07	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	751.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	52.48	2.56	0.32	0.00	0.00	0.64	0.64	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	136.36	3.67	0.92	1.84	1.84	0.00	1.38	0.46	0.00	1.38
hIPS +CCl2, biol_rep2	14384-156C1	163.24	1.37	0.46	1.83	1.83	0.00	1.37	1.37	0.00	3.66
hIPS +CCl2, biol_rep3	14385-156C2	104.99	1.93	0.00	0.00	1.93	0.00	1.29	1.29	0.00	1.29
hIPS, biol_rep1	14380-156B6	140.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.87
hIPS, biol_rep2	14381-156B7	113.85	3.43	0.69	1.37	1.37	0.00	2.06	0.69	0.00	3.43
hIPS, biol_rep3	14382-156B8	115.86	4.41	1.10	7.72	3.31	1.10	2.21	0.00	2.21	4.41
hairy cell leukemia cell line:Mo	10712-109I1	93.39	7.18	2.01	2.59	2.59	0.57	1.72	0.57	0.29	0.86
heart - mitral valve, adult	10205-103F7	131.25	5.38	2.99	1.20	0.30	0.30	1.49	2.99	1.20	0.00
heart - pulmonic valve, adult	10206-103F8	189.83	14.38	2.61	2.88	1.83	1.83	2.09	2.88	1.57	1.05
heart - tricuspid valve, adult	10207-103F9	138.22	14.99	1.67	4.16	1.67	4.16	0.83	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	39.38	3.67	0.00	0.61	0.82	0.20	0.41	0.00	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	21.29	1.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	24.15	0.00	0.46	0.00	0.00	0.00	0.23	0.23	0.00	0.23
heart, fetal, pool1	10046-101G1	143.75	1.95	0.41	1.44	0.92	0.51	1.23	0.31	0.62	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	37.64	0.62	0.00	0.00	0.31	0.62	0.31	0.00	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	158.16	3.57	0.00	1.19	1.19	3.57	2.38	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	161.54	10.39	1.66	3.43	2.32	1.33	1.33	0.77	0.55	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	164.95	12.87	0.36	2.06	2.06	1.94	1.09	0.73	0.61	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	192.91	11.22	1.21	1.52	2.83	2.43	0.91	0.81	0.91	0.51
hepatoma cell line:Li-7	10484-107A7	86.86	2.78	1.33	0.89	0.89	0.33	0.56	0.33	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	98.39	4.12	1.71	1.81	0.70	1.11	1.01	1.51	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	205.35	29.34	7.57	3.79	5.68	3.79	4.73	4.73	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	279.21	34.08	4.29	7.96	6.74	4.29	2.86	2.65	5.92	0.82
hippocampus, adult, donor10258	10374-105G5	142.41	5.48	1.00	1.00	2.99	3.49	1.00	1.49	2.99	5.98
hippocampus, newborn, donor10223	10363-105F3	75.78	3.52	0.70	0.35	1.41	0.00	0.35	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	198.97	6.10	0.61	6.71	1.22	3.66	3.05	1.22	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	104.07	4.52	0.79	1.18	2.16	1.57	2.75	0.98	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	116.03	3.30	0.51	1.52	1.52	0.51	0.51	0.76	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	146.04	8.46	1.13	4.51	0.56	1.69	1.69	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	238.33	14.46	3.36	4.39	3.10	3.10	4.91	1.29	1.81	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	216.76	4.93	0.76	1.52	1.14	1.14	1.90	1.90	1.14	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	187.43	12.85	2.04	1.17	0.00	0.58	0.29	0.88	0.58	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	174.93	9.69	1.51	3.02	3.02	1.94	1.72	1.51	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	155.57	3.34	0.83	0.00	0.42	1.25	0.00	0.83	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	174.04	0.95	1.66	0.95	0.47	0.24	0.71	0.47	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	139.82	6.43	2.25	1.77	2.25	1.13	2.89	0.96	0.32	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	156.88	0.67	2.69	0.00	0.00	0.67	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	97.96	5.79	2.03	2.19	1.25	1.41	1.41	0.47	1.25	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	118.40	6.88	1.97	3.44	3.44	1.47	2.46	1.97	1.97	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	197.24	6.98	0.00	1.75	0.00	0.00	3.49	0.87	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	197.40	10.69	8.02	2.10	2.10	0.95	1.72	0.76	0.95	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	196.23	8.29	6.54	3.92	3.49	2.18	1.31	3.05	0.44	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	237.39	9.00	3.00	2.50	1.00	1.00	2.00	1.00	0.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	94.01	4.33	1.32	2.07	1.32	0.57	1.51	1.13	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	112.77	4.09	1.82	0.45	0.45	0.91	0.45	1.82	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	93.97	8.77	1.88	0.94	0.94	0.31	1.25	0.00	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	121.66	5.23	3.27	2.78	1.63	1.47	1.96	1.31	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	109.45	4.64	3.19	2.61	4.35	2.03	0.29	1.16	0.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	108.21	6.28	2.69	0.60	1.20	0.60	0.00	1.20	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	125.44	6.47	1.29	2.59	1.29	2.03	2.40	1.48	1.29	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	97.85	3.42	2.28	2.57	1.43	1.14	2.28	0.29	0.00	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	156.38	5.31	2.04	1.22	0.82	0.82	1.22	1.22	1.22	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	201.74	7.39	4.93	2.46	1.41	2.46	5.99	1.06	0.70	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	146.65	8.24	2.22	2.53	1.90	1.58	2.53	0.00	0.95	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	137.09	3.93	2.12	1.21	0.61	0.91	1.21	0.61	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	134.45	3.62	3.10	0.52	2.59	0.00	1.55	0.00	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	130.84	5.31	4.65	1.99	0.66	1.99	0.00	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	131.34	2.05	1.03	1.28	1.03	1.03	0.51	0.26	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	128.85	4.09	1.28	1.28	1.28	1.02	0.77	1.53	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	157.50	3.03	0.76	1.51	0.00	0.00	0.00	2.27	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	96.11	2.69	0.67	1.01	0.67	1.34	0.34	1.01	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	124.38	3.86	3.14	0.97	0.48	0.97	1.21	0.48	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	139.49	6.68	1.34	3.57	1.78	2.23	2.67	0.45	0.45	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	108.29	7.32	1.95	0.98	0.49	1.46	0.49	0.98	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	202.62	9.47	3.36	4.58	2.44	1.22	1.53	0.92	1.22	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2339.08	61.81	3.25	32.53	6.51	19.52	22.77	13.01	6.51	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	255.82	7.61	5.30	2.98	1.32	2.65	5.63	1.32	0.00	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	183.89	3.83	1.09	1.09	1.09	0.00	1.64	0.55	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	131.36	4.34	1.81	3.98	0.36	0.36	1.45	1.45	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	150.18	4.63	2.85	2.49	0.71	0.71	0.00	0.00	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	149.17	1.19	3.58	4.77	5.97	0.00	1.19	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	218.71	2.17	1.22	1.35	1.49	1.08	1.22	0.41	0.14	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	103.72	5.66	2.69	1.08	1.08	0.81	0.81	0.81	0.54	0.27
immature langerhans cells, donor1	11904-125F5	49.40	0.73	0.00	0.24	0.00	0.00	0.24	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	86.34	0.79	1.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	74.38	2.37	0.57	1.04	0.76	0.38	0.57	0.19	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	38.37	4.23	0.65	0.33	0.33	0.33	0.98	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	71.19	2.10	0.20	0.70	0.70	0.90	0.90	0.20	0.50	0.30
kidney, fetal, pool1	10045-101F9	95.85	0.92	0.14	0.35	0.42	0.21	0.35	0.07	0.07	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	133.64	1.28	1.14	0.00	0.43	0.43	0.14	0.14	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	66.49	1.24	0.97	0.69	0.14	0.00	0.28	0.14	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	58.54	1.47	0.37	0.18	0.18	0.18	0.00	0.37	0.37	0.00
left atrium, adult, donor1	10079-102A7	19.07	5.45	0.00	1.09	1.09	0.00	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	10.62	1.52	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	73.33	3.28	1.64	1.09	1.09	0.55	1.09	0.27	0.82	1.37
leiomyoma cell line:10964C	10569-108B2	14.01	0.00	0.00	0.72	0.00	0.36	0.00	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	18.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	34.72	1.46	0.24	0.00	0.00	0.24	0.00	0.00	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	192.38	2.09	3.14	0.00	0.00	0.00	1.05	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	147.45	7.79	1.89	2.83	2.48	2.60	1.65	1.65	0.47	0.59
liposarcoma cell line:KMLS-1	10782-110G8	77.95	6.40	0.62	0.31	0.94	0.47	0.47	0.47	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	71.89	2.80	0.61	0.49	0.73	0.85	0.37	0.24	0.00	0.37
liver, adult, pool1	10018-101C9	32.41	0.49	0.00	0.00	0.32	0.49	0.16	0.16	0.16	0.16
liver, fetal, pool1	10086-102B5	17.87	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	176.74	20.12	2.19	5.54	7.58	5.25	2.33	0.73	3.79	1.31
locus coeruleus, adult, donor10252	10165-103B3	179.75	22.88	1.85	4.61	3.69	2.40	2.21	2.95	2.21	1.29
locus coeruleus, adult, donor10258	10375-105G6	81.54	3.67	3.39	1.13	1.69	0.56	1.69	2.54	0.85	0.85
locus coeruleus, newborn, donor10223	10362-105F2	181.29	5.47	1.68	1.26	1.68	2.94	0.42	0.84	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	49.96	0.55	0.00	0.42	0.14	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	183.38	0.69	0.00	0.00	2.07	0.00	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	121.01	1.85	0.79	0.53	0.79	0.53	1.58	0.66	0.26	0.13
lung, adult, pool1	10019-101D1	68.16	2.13	0.24	0.35	0.12	0.35	0.12	0.12	0.12	0.24
lung, fetal, donor1	10068-101I5	479.20	1.71	4.57	1.14	0.57	0.00	0.29	0.57	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	70.11	10.54	1.83	1.37	1.37	0.46	1.37	2.29	0.92	1.83
lymph node, adult, donor1	10077-102A5	30.30	3.31	0.00	0.95	0.47	0.00	0.47	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	55.23	4.82	1.32	0.88	0.88	0.66	0.44	0.22	0.88	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	150.32	3.32	0.00	0.91	0.60	0.15	0.15	0.30	0.45	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	234.46	2.55	0.85	2.55	0.85	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	40.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	51.47	0.83	0.42	0.21	0.21	0.00	0.00	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	62.58	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	64.49	0.00	0.26	0.00	0.00	0.00	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	226.35	2.38	0.48	2.62	0.71	0.48	0.71	0.71	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	253.81	15.79	1.13	3.38	4.51	5.64	1.13	1.13	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	264.46	25.93	2.02	7.91	6.62	5.52	4.60	1.29	3.49	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	97.85	12.39	0.95	1.91	3.18	2.86	1.91	2.22	1.91	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	215.80	13.65	0.43	5.97	5.54	2.56	2.56	2.13	1.28	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	313.37	22.95	4.05	11.98	10.13	11.31	4.39	3.88	3.21	2.53
medial temporal gyrus, adult, donor10252	10156-103A3	299.24	37.56	3.18	10.40	11.25	6.37	3.40	4.24	9.13	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	130.99	17.34	0.00	3.85	5.78	3.85	3.85	3.85	0.00	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	6502.19	287.07	14.35	100.48	215.30	157.89	86.12	71.77	114.83	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	88.30	4.31	0.72	1.44	2.15	0.36	0.72	0.72	0.00	0.72
medulla oblongata - adult, donor10196	10174-103C3	195.99	17.52	1.95	1.95	5.84	3.89	0.65	3.24	1.30	1.95
medulla oblongata, adult, donor10252	10155-103A2	266.11	22.60	1.86	6.04	3.56	4.18	2.94	2.01	2.48	0.93
medulla oblongata, adult, pool1	10038-101F2	55.51	1.14	0.24	0.57	0.33	0.16	0.24	0.16	0.08	0.00
medulla oblongata, newborn, donor10223	10361-105F1	97.21	6.94	3.12	1.04	1.74	1.04	2.08	0.35	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1320.06	52.70	10.41	23.25	22.14	17.27	14.83	11.07	9.08	8.41
medulloblastoma cell line:ONS-76	10759-110E3	79.84	2.69	0.49	0.86	1.47	1.10	1.96	0.61	0.24	0.24
melanoma cell line:COLO 679	10514-107E1	65.40	1.44	0.29	0.43	0.72	0.14	0.29	0.14	0.14	0.29
melanoma cell line:G-361	10465-106H6	67.32	5.43	0.54	1.09	1.63	0.54	0.27	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	31.84	0.72	0.90	0.00	0.54	0.36	0.00	0.18	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	884.68	51.11	12.34	6.17	13.22	3.52	8.81	3.52	5.29	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	357.99	13.48	7.00	2.59	1.30	0.52	1.56	1.04	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	52.93	1.84	0.15	0.61	0.61	0.15	0.77	0.46	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	51.99	1.82	1.27	0.55	0.00	0.36	0.91	0.36	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	49.69	1.66	0.83	0.41	0.00	0.00	0.00	0.41	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.89	1.26	0.56	0.28	0.28	0.42	0.14	0.56	0.00	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	41.79	0.77	1.73	0.39	0.58	0.00	0.58	0.00	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	46.50	1.39	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.53	0.51	0.34	0.17	0.17	0.34	0.00	0.17	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	47.73	0.58	0.46	0.46	0.35	0.23	0.12	0.00	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	40.98	0.40	0.27	0.27	0.40	0.00	0.53	0.13	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	46.05	1.49	0.81	0.14	0.68	0.41	0.14	0.41	0.14	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	59.61	1.00	0.43	0.57	0.71	0.28	0.85	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	47.43	2.31	1.65	0.00	0.00	0.33	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	49.95	1.80	0.97	0.83	0.14	0.28	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	38.05	1.05	1.05	0.00	1.05	0.00	0.70	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	47.37	1.43	2.04	0.20	0.41	0.00	0.41	0.00	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	35.23	3.24	1.80	0.36	1.08	0.00	0.00	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.31	0.62	0.62	0.21	0.10	0.00	0.41	0.21	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.06	0.46	1.14	0.23	0.00	0.00	0.00	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	94.40	2.94	0.42	0.42	0.00	0.00	0.84	1.26	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	61.42	1.05	1.94	0.15	0.45	0.15	0.30	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	50.51	1.40	0.88	0.53	0.26	0.35	0.26	0.35	0.00	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	59.64	5.15	0.74	0.37	0.37	0.00	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	54.08	3.15	0.29	0.29	0.29	0.29	0.29	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	65.68	2.53	1.26	1.26	2.95	0.00	0.00	0.00	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.08	0.46	0.00	0.00	0.00	0.00	0.91	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	43.23	0.51	0.51	1.28	0.26	0.26	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.95	0.79	0.26	0.52	0.00	0.52	0.79	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.89	0.92	0.62	0.92	0.92	0.31	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	47.54	1.18	0.71	0.47	0.47	0.00	0.24	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.37	0.68	0.00	0.34	0.00	0.00	0.68	0.34	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	47.94	0.39	0.39	1.18	1.18	0.39	0.39	0.39	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	41.24	0.93	1.39	0.46	0.00	0.00	0.00	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.30	0.29	0.29	0.29	0.29	0.00	0.58	0.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	45.07	1.12	0.89	0.67	0.22	0.00	0.22	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	41.34	0.48	1.20	0.24	0.48	0.48	0.48	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.07	1.47	0.00	0.00	0.73	0.00	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.61	0.67	1.01	1.34	0.34	0.34	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	39.30	0.00	1.23	0.41	0.82	0.82	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.25	1.29	0.43	0.86	0.00	0.00	0.00	0.43	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	0.00	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	0.00	0.00	0.00	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	29.88	0.97	0.32	0.00	0.00	0.00	0.65	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	45.10	1.45	1.45	0.00	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	0.00	0.53	0.00	0.53	0.00	0.00	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	30.26	1.64	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.93	0.78	0.39	0.00	0.78	0.00	0.00	0.78	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	31.79	1.99	0.00	0.00	0.99	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	0.00	4.77	0.00	4.77	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	41.51	1.19	0.00	0.00	1.19	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	38.99	1.22	1.22	0.00	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	26.60	0.00	0.00	0.00	0.63	0.63	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	52.77	1.03	2.41	0.69	0.34	0.00	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	55.88	0.00	6.45	0.00	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	0.00	0.00	0.00	3.44	0.00	3.44	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	52.16	1.22	1.22	0.41	2.04	0.00	2.04	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	68.32	1.59	0.79	1.59	0.00	0.00	1.59	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	40.68	1.77	2.36	2.36	0.00	0.59	1.77	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	61.41	1.87	2.18	0.62	0.31	1.25	0.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	64.16	2.67	1.34	1.34	0.00	1.34	1.34	1.34	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	54.40	4.73	0.00	1.18	0.00	0.00	0.00	1.18	1.18	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	59.06	0.00	0.00	2.57	2.57	2.57	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	60.58	0.00	0.00	0.69	2.75	2.07	0.69	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	52.94	4.45	0.00	0.99	0.99	0.49	1.48	0.00	0.99	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	1.12	0.00	1.12	1.12	1.12	1.12	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	55.97	1.91	0.64	4.45	1.27	0.64	1.91	0.00	1.27	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.96	1.21	0.00	0.81	0.00	0.00	0.00	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	1.21	1.21	0.00	0.00	0.00	0.61	0.61	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	0.00	0.00	4.52	0.00	4.52	9.04	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	59.30	6.59	0.82	1.65	3.29	1.65	3.29	2.47	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	48.61	0.40	1.59	0.00	0.20	0.20	0.00	0.20	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.37	0.97	0.65	0.65	0.32	0.32	0.32	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	46.86	4.07	1.02	1.02	1.02	0.00	2.04	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	97.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	81.50	1.89	0.94	0.24	0.71	0.00	0.00	0.24	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	55.60	2.09	0.46	0.23	0.46	0.46	0.46	0.23	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	66.38	1.44	0.41	0.31	0.62	0.21	0.41	0.62	0.41	0.31
mesothelioma cell line:Mero-25	10850-111F4	20.88	1.13	0.23	0.00	0.23	0.45	0.23	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	86.79	3.67	0.00	0.24	0.73	0.49	0.49	0.49	0.24	0.49
mesothelioma cell line:Mero-48a	10852-111F6	57.79	2.66	1.33	0.89	1.55	1.11	0.22	0.66	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	66.49	3.94	1.05	1.31	2.37	1.31	1.58	0.53	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	116.26	6.81	1.53	2.89	1.36	1.87	1.19	1.70	0.68	2.21
mesothelioma cell line:Mero-84	10855-111F9	20.22	0.76	0.25	0.25	0.00	0.00	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	32.51	2.28	0.00	0.62	0.83	0.21	0.62	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	57.65	3.31	0.66	0.66	0.50	0.66	0.83	1.16	0.17	0.50
mesothelioma cell line:NCI-H226	10846-111E9	51.58	2.53	0.36	0.90	0.90	1.45	0.54	0.72	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	93.27	3.42	0.51	1.02	1.54	0.85	1.54	0.34	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	150.13	6.62	1.78	3.82	2.54	0.51	2.80	2.04	0.25	2.29
mesothelioma cell line:No36	10857-111G2	61.00	3.91	0.00	1.30	0.00	0.98	0.65	0.98	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	56.90	1.35	1.08	0.27	1.35	0.54	0.54	0.54	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	86.75	1.73	0.19	0.38	0.19	0.19	0.19	0.77	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	51.65	0.49	0.12	0.00	0.00	0.00	0.00	0.12	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	88.84	0.72	0.36	0.18	0.18	0.00	0.00	0.00	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.09	3.26	2.61	1.31	0.65	0.33	0.65	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	35.39	2.12	0.64	0.00	0.64	0.00	0.21	0.21	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	71.18	3.46	0.46	0.46	0.23	0.69	0.92	0.46	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	52.33	2.09	0.19	0.38	0.19	0.19	0.38	0.76	0.19	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	202.16	3.88	0.74	0.92	1.11	0.18	0.74	0.55	0.00	0.18
myeloma cell line:PCM6	10474-106I6	64.04	2.37	0.99	0.99	1.38	0.99	0.00	0.79	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	72.04	4.06	2.03	0.51	2.03	1.01	2.03	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	49.03	0.59	0.78	0.00	0.20	0.20	0.20	0.20	0.00	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.85	0.11	0.56	0.00	0.00	0.11	0.22	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.11	0.22	0.37	0.00	0.07	0.00	0.07	0.00	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	27.60	0.00	0.55	0.00	0.00	0.00	0.00	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	721.93	12.88	7.13	2.07	1.38	1.61	0.92	0.69	0.23	1.38
neuroblastoma cell line:NB-1	10539-107G8	294.66	4.49	4.12	2.25	2.06	0.56	0.56	0.75	0.19	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	160.49	9.07	4.22	2.32	2.53	2.74	1.90	1.48	0.42	1.05
neuroblastoma cell line:NH-12	10555-107I6	512.09	17.33	7.83	7.83	8.57	5.40	3.91	3.91	2.98	5.22
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	425.58	35.82	6.64	6.17	11.15	7.59	5.22	4.27	1.66	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	167.88	8.08	3.01	2.38	2.69	2.53	1.27	1.58	1.11	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	111.30	10.26	2.01	0.40	2.01	1.41	1.01	1.21	0.60	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	137.96	4.45	0.00	1.91	2.54	1.27	1.91	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	36.73	0.80	0.53	0.27	0.27	0.00	0.27	0.80	0.00	0.00
neutrophil PMN, donor1	12133-128D9	223.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	770.01	20.97	7.44	7.10	5.24	2.71	2.88	2.88	1.86	1.69
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	187.32	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.02	2.56	0.64	0.64	0.32	0.00	0.32	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.73	0.79	1.84	0.26	0.53	0.00	0.26	0.00	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	114.46	2.91	0.09	1.22	1.22	1.50	0.84	0.28	0.19	0.56
occipital cortex - adult, donor10196	10172-103C1	352.33	24.72	2.06	2.06	0.00	0.00	4.12	4.12	4.12	6.18
occipital cortex, adult, donor10252	10163-103B1	332.50	42.40	7.25	8.86	8.32	5.64	4.56	4.03	7.25	1.88
occipital cortex, newborn, donor10223	10355-105E4	116.10	3.64	1.46	0.36	1.82	1.09	0.00	0.00	1.09	0.73
occipital lobe, adult, donor1	10076-102A4	98.14	7.08	2.62	0.52	0.00	0.26	0.00	3.15	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	224.85	32.61	4.72	1.29	2.57	1.72	0.86	6.87	0.86	0.43
occipital pole, adult, pool1	10036-101E9	40.37	0.55	0.24	0.55	0.08	0.08	0.16	0.24	0.16	0.08
olfactory region, adult	10195-103E6	179.78	12.61	1.91	7.64	6.88	6.50	3.25	1.91	6.88	2.67
optic nerve, donor1	10277-104E7	238.12	12.01	6.00	2.00	0.00	0.00	0.00	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	135.32	3.99	0.34	1.03	1.03	0.68	0.23	0.46	0.23	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	98.37	1.10	1.37	0.41	0.41	0.00	0.41	0.41	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	91.10	4.57	0.68	1.02	1.02	0.51	0.17	0.85	1.19	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	48.40	1.50	0.58	0.81	0.46	0.69	0.12	0.58	0.46	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	30.28	0.88	0.88	0.88	0.00	0.00	0.00	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	166.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	100.52	2.76	1.06	0.21	0.85	0.42	1.06	0.21	0.21	0.21
ovary, adult, pool1	10020-101D2	83.33	1.57	0.00	0.52	0.26	0.79	0.35	0.35	0.09	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	36.85	2.02	0.37	0.92	1.10	0.18	0.18	0.18	0.55	0.00
pancreas, adult, donor1	10049-101G4	61.14	1.88	0.94	0.94	0.94	0.94	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	68.77	3.07	1.40	1.40	1.12	0.56	0.84	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	97.61	7.67	2.73	1.19	0.85	1.53	0.68	1.19	0.85	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	104.65	0.83	0.83	0.66	0.50	0.66	0.50	0.00	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	91.61	3.29	0.27	1.65	0.92	0.73	1.37	0.18	0.37	0.46
parietal cortex, adult, donor10258	10373-105G4	128.45	9.54	0.73	2.94	4.40	1.47	1.47	1.47	2.94	5.87
parietal lobe - adult, donor10196	10171-103B9	212.55	23.51	2.82	5.64	4.70	5.64	0.94	1.88	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	286.46	33.35	3.71	7.13	6.56	4.56	2.28	2.85	7.70	2.00
parietal lobe, adult, pool1	10034-101E7	74.81	1.94	0.09	1.23	1.15	0.79	0.62	0.09	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	279.31	30.06	7.76	3.88	15.52	3.88	8.73	11.64	2.91	4.85
parietal lobe, newborn, donor10223	10356-105E5	117.39	8.97	0.37	2.99	1.87	2.62	1.50	1.12	1.50	1.12
parotid gland, adult	10199-103F1	30.22	0.00	1.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	133.74	12.35	3.76	4.83	3.22	2.69	3.22	2.15	1.61	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	52.43	1.30	1.12	0.56	0.56	0.00	0.37	0.56	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.78	3.21	2.33	0.58	0.29	1.17	0.58	0.58	0.00	0.58
pineal gland - adult, donor10196	10179-103C8	256.08	15.48	1.94	1.94	1.94	0.65	1.29	5.16	2.58	1.29
pineal gland, adult, donor10252	10160-103A7	348.81	24.87	2.37	2.96	2.96	2.37	1.78	1.78	2.37	1.78
pineal gland, adult, donor10258	10377-105G8	137.96	6.90	2.51	2.51	1.88	1.88	1.25	1.25	1.25	3.14
pituitary gland - adult, donor10196	10180-103C9	365.26	19.22	4.05	4.05	6.07	7.08	3.04	2.02	1.01	5.06
pituitary gland, adult, donor10252	10162-103A9	508.15	10.42	2.08	4.17	3.13	4.17	1.04	2.08	2.08	1.04
pituitary gland, adult, donor10258	10378-105G9	166.84	11.07	2.55	5.96	5.11	4.26	7.66	1.70	0.00	1.70
placenta, adult, pool1	10021-101D3	60.52	1.08	0.11	0.65	0.54	0.22	0.11	0.43	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	140.11	5.43	1.99	0.79	1.06	1.06	0.66	1.06	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	131.83	2.80	1.25	0.47	0.31	0.00	0.31	0.16	0.31	0.16
pons, adult, pool1	10033-101E6	131.60	2.58	0.17	1.89	1.72	0.77	1.29	0.09	0.60	0.43
postcentral gyrus, adult, pool1	10032-101E5	51.17	1.05	0.44	0.44	0.26	0.09	0.35	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	365.99	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	104.15	7.43	1.89	2.04	1.46	0.87	1.31	0.44	0.15	0.87
prostate cancer cell line:PC-3	10439-106E7	156.64	13.61	2.90	2.36	3.09	3.27	1.45	1.45	0.73	0.73
prostate, adult, pool1	10022-101D4	93.41	2.27	0.45	0.63	0.45	0.45	0.36	0.36	0.54	0.36
putamen, adult, donor10196	10176-103C5	265.34	20.30	3.07	5.19	6.85	4.49	3.30	2.12	3.78	0.71
putamen, adult, donor10252	10152-102I8	284.31	5.88	3.92	0.00	1.96	0.00	0.00	1.96	9.80	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	107.10	7.65	1.09	3.28	0.00	4.37	3.28	1.09	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	131.68	6.52	1.45	5.07	4.35	2.66	3.14	1.93	1.69	2.42
putamen, newborn, donor10223	10365-105F5	209.16	9.00	0.75	3.00	3.75	4.50	0.75	1.50	2.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	141.10	3.20	1.16	1.16	0.29	0.87	0.58	0.00	0.87	0.58
rectum, fetal, donor1	10067-101I4	143.27	19.47	0.00	0.00	1.39	1.39	2.78	6.95	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	99.22	0.64	0.64	0.85	0.21	0.21	1.06	0.64	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.65	4.97	2.07	0.41	0.83	0.83	0.00	0.41	0.41	0.41
retina, adult, pool1	10030-101E3	96.62	1.79	0.30	0.80	0.40	0.40	0.40	0.50	0.00	0.30
retinoblastoma cell line:Y79	10475-106I7	454.65	43.91	7.27	4.68	7.27	4.94	1.30	2.60	2.08	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	89.26	6.64	0.74	2.09	2.09	1.84	1.11	0.61	0.12	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	405.21	8.15	2.53	1.41	1.41	1.12	0.56	0.84	0.56	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.23	1.52	0.76	0.00	0.00	0.00	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	89.99	4.05	0.97	2.43	1.94	2.27	1.94	1.94	0.81	0.65
salivary acinar cells, donor2	11772-123I8	124.88	5.92	1.38	2.07	2.34	1.24	3.17	0.69	0.14	0.96
salivary acinar cells, donor3	11773-123I9	200.60	6.62	1.32	5.30	1.32	1.99	1.99	0.66	2.65	0.66
salivary gland, adult, pool1	10093-102C3	34.89	0.57	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	69.14	1.43	0.42	0.51	0.59	0.17	0.00	0.25	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	65.83	4.82	0.82	1.06	0.24	0.47	0.35	0.24	0.47	0.35
seminal vesicle, adult	10201-103F3	126.45	11.11	7.41	1.06	4.23	2.65	2.65	4.76	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	159.60	8.50	4.62	1.21	1.70	0.73	1.70	1.94	1.21	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	28.69	1.01	0.00	0.25	0.00	0.00	0.25	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	2.01	1.00	0.00	0.00	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	92.68	4.03	0.81	1.48	1.61	0.81	0.54	1.07	0.54	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	123.57	1.88	1.11	0.55	0.66	0.66	0.33	0.11	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	110.06	2.45	0.90	0.26	0.52	0.00	0.13	0.65	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	131.23	17.02	0.00	0.71	1.42	0.00	0.71	0.00	3.55	0.71
skeletal muscle, adult, pool1	10023-101D5	48.93	0.48	0.00	0.24	0.36	0.12	0.12	0.24	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	17.09	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	136.35	14.52	2.52	0.00	0.00	0.63	2.52	4.42	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	83.71	6.67	2.33	1.33	0.33	0.67	2.33	1.00	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	306.69	30.57	4.73	5.67	8.20	5.36	4.73	2.52	0.95	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	181.76	4.05	4.43	0.96	1.35	0.77	1.35	0.19	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	236.86	5.60	2.14	1.81	0.82	1.65	1.15	0.49	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	799.74	39.57	13.03	12.39	13.83	9.81	6.11	10.62	4.18	3.86
small cell lung carcinoma cell line:WA-hT	10562-108A4	88.91	4.14	2.18	1.53	1.96	0.44	1.09	1.09	0.22	1.31
small intestine, adult, pool1	10024-101D6	94.12	1.91	0.60	1.19	0.48	0.12	0.36	0.36	0.60	0.36
small intestine, fetal, donor1	10064-101I1	98.52	15.97	1.23	1.23	1.47	2.70	2.21	0.25	0.74	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	72.83	2.05	1.03	0.51	0.51	1.03	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	114.75	8.01	1.29	2.07	1.55	1.29	3.88	0.78	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	89.25	2.41	0.54	0.54	1.07	0.54	0.27	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	186.05	30.74	1.15	4.13	3.90	4.13	2.29	1.84	3.67	1.61
spinal cord, adult, donor10252	10159-103A6	386.39	13.80	1.58	3.15	5.13	2.37	2.76	2.76	3.15	3.55
spinal cord, adult, donor10258	10369-105F9	218.61	13.84	2.08	1.38	2.77	3.46	2.77	4.84	0.69	4.84
spinal cord, fetal, donor1	10056-101H2	113.43	14.64	4.27	0.61	0.61	0.61	0.61	1.83	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	216.29	16.53	0.46	3.67	2.30	3.67	3.21	2.30	2.30	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	37.19	1.19	0.15	0.45	1.19	0.30	0.45	0.30	0.15	0.15
spleen, adult, pool1	10025-101D7	77.20	1.43	0.11	0.22	0.33	0.55	0.22	0.00	0.33	0.22
spleen, fetal, pool1	10044-101F8	75.09	0.40	0.40	0.40	0.16	0.16	0.24	0.08	0.16	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	130.74	4.45	0.62	2.07	2.38	1.04	1.35	0.83	0.31	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	119.62	6.84	1.33	0.95	1.33	0.76	0.57	0.95	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	84.92	9.44	0.35	1.40	1.75	1.40	0.70	0.35	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	32.45	0.39	0.00	0.00	0.00	0.00	0.39	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	88.02	2.93	1.01	0.11	0.56	0.45	0.23	0.34	0.34	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	89.80	3.39	0.00	0.85	1.27	1.27	0.42	0.42	0.00	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	77.84	2.54	0.42	0.42	0.85	0.00	0.00	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	195.44	9.61	3.20	1.07	0.00	1.07	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	97.42	4.56	0.57	0.00	0.00	0.00	0.00	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	4070.56	2062.42	271.37	488.47	814.11	1302.58	217.10	162.82	108.55	325.64
substantia nigra, adult, donor10252	10158-103A5	314.47	33.03	6.02	8.52	7.06	4.98	4.78	1.66	3.32	0.62
substantia nigra, adult, donor10258	10371-105G2	132.93	6.72	0.52	3.62	1.55	3.10	2.59	1.03	1.55	3.62
substantia nigra, newborn, donor10223	10358-105E7	95.39	13.42	2.12	2.12	2.83	1.41	0.00	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	161.40	11.23	2.29	3.44	1.83	3.44	1.38	1.83	0.46	1.60
temporal lobe, adult, pool1	10031-101E4	41.28	0.76	0.08	0.51	0.00	0.17	0.51	0.25	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	237.19	31.34	4.99	1.42	2.14	0.71	2.14	7.83	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	235.59	12.31	2.64	0.88	1.76	0.44	0.88	4.40	0.44	0.00
tenocyte, donor1	11763-123H8	56.55	1.75	1.75	0.70	1.40	1.05	0.35	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	60.28	1.91	2.67	1.91	0.38	1.53	0.76	0.76	0.76	0.00
tenocyte, donor3	11768-123I4	57.82	2.97	1.85	0.74	1.85	0.37	1.11	1.48	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	149.57	10.20	1.70	3.40	1.53	2.21	3.23	1.19	1.70	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	61.66	5.09	0.62	0.77	0.46	0.31	0.62	0.62	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	98.72	6.20	1.86	2.17	1.55	2.17	1.70	1.70	0.31	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	78.58	4.57	0.89	0.63	0.89	1.14	0.51	0.51	1.02	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	125.93	1.89	1.13	0.00	2.27	1.51	0.38	0.38	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	118.33	2.73	0.98	0.76	0.98	0.44	0.76	0.44	0.22	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	89.57	9.45	0.33	1.95	1.95	1.63	1.30	1.95	0.33	0.98
testis, adult, pool1	10026-101D8	52.08	1.61	0.11	0.64	0.32	0.32	0.43	0.11	0.21	0.00
testis, adult, pool2	10096-102C6	75.33	5.41	0.00	0.90	0.90	0.00	0.90	1.35	0.90	0.00
thalamus - adult, donor10196	10168-103B6	287.04	37.54	8.83	1.10	6.62	4.42	1.10	1.10	5.52	0.00
thalamus, adult, donor10252	10154-103A1	329.44	30.01	3.91	6.41	6.56	6.41	4.53	2.03	2.50	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	181.67	6.16	3.08	4.62	4.62	0.00	1.54	0.00	1.54	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	61.59	7.25	0.99	1.15	2.31	1.48	1.15	1.81	0.66	0.66
thalamus, newborn, donor10223	10366-105F6	68.46	6.33	0.58	0.58	1.15	0.00	0.00	0.00	1.73	0.58
throat, adult	10209-103G2	127.58	3.25	0.50	0.50	0.50	0.00	0.00	1.00	0.50	0.75
throat, fetal, donor1	10061-101H7	124.62	11.88	2.13	1.22	0.61	1.22	0.61	2.13	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	275.84	12.72	7.55	2.58	3.18	2.19	1.39	1.79	0.79	0.99
thymus, adult, pool1	10027-101D9	109.75	1.89	0.30	0.70	0.40	0.40	0.80	0.30	0.20	0.00
thymus, fetal, pool1	10043-101F7	285.01	4.16	0.94	2.81	1.66	1.87	1.45	0.31	0.21	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	60.23	1.20	0.66	0.40	0.80	0.53	0.53	0.13	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	87.73	6.84	2.37	2.37	1.82	1.40	1.54	1.96	0.14	0.42
thyroid, adult, pool1	10028-101E1	92.38	1.40	0.56	0.84	0.56	0.47	0.19	0.28	0.28	0.56
thyroid, fetal, donor1	10060-101H6	109.68	19.51	3.43	5.27	3.69	1.58	2.64	2.90	2.11	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	129.34	46.19	3.08	0.00	9.24	3.08	0.00	6.16	3.08	0.00
tongue, adult	10203-103F5	82.33	3.26	0.23	1.40	2.09	1.40	0.70	1.63	1.40	0.00
tongue, fetal, donor1	10059-101H5	94.98	11.43	1.18	2.36	1.58	1.58	1.97	1.58	0.39	0.39
tonsil, adult, pool1	10047-101G2	67.42	0.60	0.40	0.20	0.00	0.10	0.00	0.00	0.00	0.00
trachea, adult, pool1	10029-101E2	70.02	1.15	0.16	0.16	0.33	0.33	0.16	0.57	0.16	0.16
trachea, fetal, donor1	10058-101H4	98.10	10.39	0.77	1.54	0.38	2.31	1.92	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.49	2.13	0.35	0.00	0.35	0.35	0.35	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	162.92	1.62	0.81	0.81	0.51	0.71	0.20	0.20	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	118.61	8.62	1.88	1.72	1.41	1.25	1.41	1.57	0.63	0.63
tridermal teratoma cell line:HGRT	10694-109G1	30.44	1.90	1.90	1.90	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	59.17	2.12	0.42	0.76	0.59	0.42	0.93	0.42	0.34	0.25
umbilical cord, fetal, donor1	10057-101H3	43.82	4.17	2.09	0.00	0.00	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	135.14	1.37	0.34	0.51	0.34	0.17	0.51	1.02	0.34	0.85
uterus, fetal, donor1	10055-101H1	124.40	9.73	1.02	2.05	2.05	2.56	2.05	1.02	1.02	1.02
vagina, adult	10204-103F6	120.19	3.23	0.65	0.00	0.00	0.00	1.94	0.00	1.29	0.00
vein, adult	10191-103E2	85.05	2.41	1.10	0.22	1.10	0.00	0.00	0.22	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	75.84	4.54	1.34	0.00	0.53	0.53	1.07	0.53	0.00	1.07